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1 Introduction 
Infectious diseases still belong to one of the leading causes of deaths worldwide with 
about 15% deaths per year, coming immediately after cardiovascular diseases. 
Besides respiratory infections, gastrointestinal diseases are one of the predominant 
infectious diseases. In 2004 2.2 million people died due to diarrheal diseases, which 
are a major problem in developing countries (WHO, GBD report 2004 update). Even 
in Germany 50% of all reported infectious diseases are infections of the 
gastrointestinal tract. The agents of gastrointestinal diseases are mainly Salmonella, 
enterohaemorrhagic Escherichia coli (EHEC), Campylobacter and Yersinia 
(Epidemiologisches Bulletin 46/2003, RKI). In 2014 2485 cases of Yersiniosis were 
reported in Germany (Epidemiologisches Bulletin 20/2015, RKI).  
However, in general infection processes are still not fully understood. For instance, 
questions regarding regulatory mechanisms controlling the expression of virulence 
factors during the infection remain to be analyzed. Recently, it was shown that gene 
expression is not always unimodal within one bacterial population (Casadesús and 
Low, 2013). The role and mechanisms of heterogeneous expression of a virulence 
gene regulator in Y. pseudotuberculosis are investigated in this study.  
 
1.1   The genus Yersinia 
The genus Yersinia belongs to the family of Enterobacteriaceae and was named after 
Alexandre Émile Jean Yersin, who first isolated Y. pestis from buboes in Hongkong in 
1894 (Treille and Yersin, 1894). Yersinia are Gram-negative, rod-shaped bacteria, 
which can grow under facultative anaerobic conditions. Yersinia are psychotolerant 
and are able to grow between temperatures of 4°C to 43°C with an optimum between 
20°C and 30°C. Until now 18 species have been reported of which three are 
pathogenic to humans - Y. pestis, Y. pseudotuberculosis and Y. enterocolitica 
(Bottone, 1997; Chen et al., 2010; Savin et al., 2014). While Y. enterocolitica and 
Y. pseudotuberculosis only share a nucleotide identity of 60% and emerged from 
each other 42 to 187 million years ago, Y. pestis evolved from Y. pseudotuberculosis 
just 1.500 - 20.000 years ago and has a 90% nucleotide identity with 
Y. pseudotuberculosis (Achtman et al., 1999).  
Introduction  2 
 
Y. pestis is the agent of bubonic and pneumonic plague and causes severe fever, 
swollen buboes and haemorrhages. The main reservoirs of Y. pestis are rodents, but 
the bacteria were also found in prairie dogs. They are normally transmitted from 
animals to humans by fleabites and rarely from human to human by inhalation of 
aerosols (Perry and Fetherston, 1997).  
Y. pseudotuberculosis and Y. enterocolitica are food-borne pathogens that cause 
Yersiniosis, gut-associated diseases like gastroenteritis, enterocolitis and mesenterial 
lymphadenitis with symptoms such as vomiting, fever, abdominal pain and diarrhea  
(Galindo et al., 2011; Koornhof et al., 1999). Yersiniosis is typically a self-limiting 
disease, however in immune-compromised persons it can lead to septicemica with 
mortality rates of up to 75% (Deacon et al., 2003). In rare cases 
Y. pseudotuberculosis and Y. enterocolitica can also cause autoimmune diseases 
like reactive arthritis and erythema nodosum (Naktin and Beavis, 1999). The main 
reservoir of Y. pseudotuberculosis and Y. enterocolitica are animals, soil and water. 
The transmission route is fecal-oral via contaminated food or water (Galindo et al., 
2011). Even though Yersiniosis is rarely lethal, it is one of the most abundant 
bacterial zoonotic infectious diseases in the European Union (Rosner et al., 2010). 
Although transmission of the bacteria as well as the disease symptoms differ 
significantly between the human pathogenic Yersiniae, these species share a tropism 
for lymphatic tissues and resistance to phagocytosis and killing by macrophages 
(Perry and Fetherston, 1997). Furthermore they all harbor the 70 kb Yersinia 
virulence plasmid pYV (pCD1 in Y. pestis), which is important for full virulence of 
these species. The plasmid encodes several virulence factors like the Yersinia 
adhesin A (YadA), the Yersinia outer proteins (Yops) and the type three secretion 
system (T3SS). However, yadA is not expressed in Y. pestis due to an inactivating 
mutation in the gene (Chain et al., 2004). Besides plasmid pCD1, Y. pestis carries 
two additional virulence plasmids, the 100 kb plasmid pMT1 and the 9,5 kb plasmid 
pPCP1, which are important for transmission and tissue invasion of Y. pestis in fleas 
(Chain et al., 2004; Perry and Fetherston, 1997; Smego et al., 1999).  
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1.2 Pathogenesis of enteropathogenic Yersinia  
The infectious process of enteropathogenic Yersinia species is biphasic and can be 
classified in an early- and a late-phase of infection. The early-phase represents the 
start of the infection and is characterized by the expression of virulence genes 
necessary for the colonization and invasion of the host. In the later phase, genes are 
expressed which are crucial for the evasion of the immune system and for 
dissemination to deeper organs (Fig. 1.1). 
Ingestion of the bacteria takes place via uptake of contaminated food or water, e. g. 
vegetables, milk and meat products, mainly raw pork (Fredriksson-Ahomaa et al., 
2006). When entering the host Yersinia enocunter a temperature change from 
environmental to host body temperature, which is besides nutrient and iron 
availability an important signal for the bacteria to adapt their gene expression pattern 
to host conditions. After passing the stomach the bacteria reach the small intestine 
and interact in the ileum with microfold cells (M-cells), which are specialized epithelial 
cells. M-cells are part of the follicle-associated epithelial layer and characterized by a 
low amount of flat microvilli and a reduced glycocalyx. They are additionally 
characterized by a pocket at the basolateral membrane in which phagocytes are 
located (Grützkau et al., 1990). The main function of M-cells is the sampling and 
transport of antigens and microorganisms to the underlying lymphatic tissues 
(Kraehenbuhl and Neutra, 2000). Many enteropathogens like Yersinia, Salmonella 
and Shigella use the M-cells as an entry gate into the host (Grützkau et al., 1990; 
Sansonetti, 2002). The bacteria adhere to and invade the M-cells and subsequently 
reach the underlying Peyer’s patches (PP) by transcytosis. The PPs are part of the 
mucosa associated lymphoid tissue and most frequently located in the ileum. Inside 
the PP the bacteria can replicate and disseminate via the lymphatic system to 
mesenteric lymph nodes as well as systemic organs like liver, kidney and spleen 
(Marra and Isberg, 1997; Pepe and Miller, 1993). 
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Fig. 1.1 Infection route of Y. pseudotuberculosis.  
The bacteria are ingested together with contaminated food or water. After passing the stomach, they 
reach the small intestine. Yersinia are motile and express invasin, which mediates the interaction with 
M-cells in the epithelial layer via binding to β1-intergrins. The bacteria transmigrate through the M-cells 
and reach the underlying PP. Once inside the tissue they express virulence factors such as YadA, the 
T3SS and the Yop effectors to resist immune responses. From the PP bacteria disseminate to the 
mesenteric lymph nodes as well as to deeper organs like spleen, liver and kidneys (modified from 
Azizi et al., 2010; Sansonetti, 2002). 
 
1.3 Virulence factors of Y. pseudotuberculosis 
Pathogenic bacteria differ from their non-pathogenic relatives by the expression of 
virulence factors and the ability to cause disease. Usually a set of different virulence 
factors are required for colonization and invasion of a host as well as for evasion of 
the immune system. The virulence factors of Y. pseudotuberculosis are either 
encoded on the 70 kb virulence plasmid or on the chromosome. 
 
1.3.1 Adhesins and invasins 
The enteropathogenic Yersinia strains express three main adhesins - invasin (InvA), 
the attachment and invasion locus (Ail), and the Yersinia adhesion A (YadA). InvA 
and Ail are encoded on the chromosome, while the yadA gene is located on the 
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virulence plasmid pYV (Balligand et al., 1985; Bölin et al., 1982; Isberg et al., 1987; 
Miller and Falkow, 1988). Invasin is the predominant and most efficient invasion 
factor and binds to β1-integrins on the surface of M-cells and leads to the uptake into 
host cells (Dersch and Isberg, 1999; Isberg and Leong, 1990). The expression of 
invA is induced at temperatures below 30°C and crucial for the initial phase of 
infection (Nagel et al., 2001). YadA expression is induced at 37°C by the 
temperature-dependent regulator LcrF (Skurnik and Toivanen, 1992). By binding 
extracellular matrix proteins such as fibronectin, laminin and collagen, YadA also 
causes cell invasion, serum resistance, autoagglutination and resistance to 
phagocytosis (China et al., 1993; Heise and Dersch, 2006; Ruckdeschel et al., 1996; 
Skurnik et al., 1984). Ail, which is expressed at 37°C, also increases adhesion to 
epithelial cells and mediates serum resistance (Bliska and Falkow, 1992; Miller and 
Falkow, 1988).  
The first step in the infectious process is the adhesion to and invasion of intestinal 
epithelial layer. Two mechanisms of host cell entry can be distinguished: the “trigger” 
and the “zipper” mechanism (Cossart and Sansonetti, 2004; O Cróinín and Backert, 
2012). The “trigger” mechanism is used by e.g. Salmonella and Shigella. Effectors of 
the T3SS are translocated directly into host cells and activate rearrangements of the 
cytoskeleton, which results in membrane ruffling and uptake of the bacteria. The 
internalization of Yersinia into host cell occurs via the “zipper” mechanism, which is 
mediated through adherence of the bacteria to cell-surface receptors (Fig. 1.2). The 
interaction of the surface molecule invasin with β1-integrins leads to a signal 
transduction to the cytoskeleton of the host cell. Induction of actin cytoskeleton 
rearrangements mediate the formation of filopodia and lamellipodia and thereby the 
engulfment of bacteria into a membrane-bound phagosome (Oelschlaeger, 2001; 
Sansonetti, 2002).  
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Fig. 1.2 Internalization of Yersinia by the “zipper” mechanism.  
(A) Upon infection, the bacteria interact with receptors at the surface of the eukaryotic cell (1). 
Thereby, a signal is transmitted into the host cell that leads to the formation of filopodia and 
lamellipodia (2), the bacteria are engulfed (3) and internalized in vacuoles (4) (modified from O Cróinín 
and Backert, 2012). (B) Scanning electron microscopy picture of Y. pseudotuberculosis engulfed from 
the eukaryotic cell. Black bar indicates 1 µm (picture from M. Rohde, Helmholtz-Centre for Infection 
Research). 
 
1.3.2 The Yop-virulon 
Besides YadA, the virulence plasmid encodes the Yersinia outer proteins (Yops), as 
well as the Yop secretion machinery (Ysc), which assembles the T3SS (Cornelis et 
al., 1998). The T3SS is built up by a needle-like structure with a basal body, which 
spans from the inner and outer membrane of the bacterium directly into the 
eukaryotic host cell (Fig. 1.3) (Cornelis, 2002). The Yops can be divided into two 
groups, first the effector proteins (YopE, YopH, YopJ, YopM, YopT and YpkA), which 
are translocated into the cytoplasm of target cells and second YopD and YopB, which 
form together with LcrV a pore in the host cell membrane. Translocation of Yops 
requires a close contact to the eukaryotic cell (Cornelis et al., 1998; Dewoody et al., 
2013). The effector proteins inhibit the immune response, e. g. YopE, YopT and 
YpkA are described to act on Rho-GTPases and thereby disrupt cytoskeletal 
dynamics and prevent phagocytosis (Black and Bliska, 2000; Cornelis, 2002; Iriarte 
and Cornelis, 1998; Von Pawel-Rammingen et al., 2000). It was shown that YopJ is 
involved in preventing the inflammatory response e. g. by the inhibition of NF-kB, 
which results in a decreased cytokine expression (Schesser et al., 1998). 
 
BA
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Fig. 1.3 The T3SS and secretion of Yops into the host cell.  
At 37°C expression of the T3SS and Yops is activated. Upon host cell contact YopD and YopB form a 
pore in the eukaryotic cell membrane and the effector proteins YopE, YopH, YopJ, YopM, YpkA and 
YopT are secreted through the T3SS directly into to host cell, where they prevent phagocytosis and 
cytokine release (Cornelis, 2002). 
 
1.3.3 Other virulence factors 
One of the first challenges for Y. pseudotuberculosis during the infection is the 
survival in the acidic milieu of the stomach. Therefore, the bacteria express urease 
and aspartase, which produce ammonia, leading to an increase of the pH (Hu et al., 
2009, 2010). 
Inside the host, bacteria are also facing limited iron availabilities. One main strategy 
to overcome iron depletion is the expression of siderophores, which are low 
molecular mass compounds, which efficiently chelate Fe2+/Fe3+-ions. They have a 
very high affinity to Fe2+/Fe3+-ions and are secreted to the surrounding media. The 
ferric-ions, bound to the siderophore, are subsequently taken up by special iron-
uptake systems. In Y. pseudotuberculosis the siderophore yersiniabactin, encoded 
on the high-pathogenicity island (HPI), functions as iron chelator and is important for 
virulence (Carniel et al., 1992; Heesemann, 1987).  
The cytotoxic necrotizing factor CNFY, which is only present in some 
Y. pseudotuberculosis strains such as YPIII, targets Rho-GTPases in particular RhoA 
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(Hoffmann et al., 2004; Lockman et al., 2002). The toxin enhances the delivery of 
Yop effector proteins, targets the host-immune response and is crucial for virulence 
of Y. pseudotuberculosis YPIII (Schweer et al., 2013). 
 
1.4 Regulation of gene expression in Y. pseudotuberculosis 
Tight regulation of gene expression is important for rapid adaptation to changing 
environments. Most pathogenic bacteria frequently change between an internal and 
an external lifestyle, where temperature, ion and nutrient availabilities differ 
dramatically. For instance, genes involved in the evasion of host immune responses 
are not needed under environmental conditions. To adjust the gene expression 
pattern to these different conditions, bacteria have to recognize whether they are 
outside or inside a host. Temperature belongs to the most important parameters, 
which are used by pathogenic bacteria to sense their environment. 
The expression of genes on the virulence plasmid pYV for example is controlled by 
the low calcium response F protein (LcrF), an AraC-type DNA-binding protein that is 
regulated by temperature on transcriptional and translational level (Fig. 1.4) (Hoe et 
al., 1992; Rouvroit et al., 1992; Skurnik and Toivanen, 1992). lcrF is located in an 
operon with yscW on the virulence plasmid (Böhme et al., 2012). YscW is one of the 
Ysc proteins, which are involved in the assembly of the T3SS and functions as pilot 
protein of YscS (Burghout et al., 2004). At moderate temperatures the polycistronic 
yscW-lcrF mRNA forms two stem-loops in the intergenic region of yscW and lcrF. 
This structure masks the ribosomal binding site (RBS) and prevents translation of 
lcrF. The stem-loop structure melts at 37°C which facilitates translation of lcrF and 
subsequent binding of LcrF to its target genes (Böhme et al., 2012). Additionally, lcrF 
expression is regulated by the Yersinia modulator A (YmoA). At moderate 
temperatures YmoA binds to the 5'UTR of the yscW-lcrF operon and represses the 
transcription of lcrF. At 37°C YmoA is degraded by Clp and Lon proteases, whereby 
transcription of lcrF can occur (Böhme et al., 2012). 
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Fig. 1.4 Model of temperature-dependent regulation of lcrF. 
At 25°C transcription of yscW-lcrF is repressed by YmoA. Additionally, stem-loop structures in the 
intergenic region of the polycistronic yscW-lcrF mRNA mask the RBS and prevents translation of lcrF. 
At 37°C YmoA is degraded by proteases. Furthermore, the stem-loop structure melts, translation of 
lcrF can occur and LcrF-dependent genes are expressed (according to Böhme et al., 2012). 
 
Another strategy for bacteria to sense whether they are inside or outside a host are 
two-component systems. They mostly consist of a membrane-spanning sensor 
kinase and a response regulator. The sensor kinase recognizes certain extracellular 
signals such as nutrients or ions and transduces the signal to the response regulator, 
which is phosphorylated by the sensor kinase. This leads to DNA-binding of the 
response regulator and thereby to activation or repression of target genes. 
Y. pseudotuberculosis expresses several two-component systems, which are 
relevant for pathogenesis like PhoP/PhoQ and BarA/UvrY (Grabenstein et al., 2004; 
Heroven et al., 2008).  
 
1.4.1 The two-component system PhoP/PhoQ 
The PhoP/PhoQ two-component system can be found in many pathogenic bacteria 
such as S. enterica serovar Typhimurium, Mycobacterium tuberculosis, Shigella 
flexneri, Pseudomonas aeruginosa and Yersinia spp. It plays an important role in 
virulence, for instance in the survival and proliferation inside macrophages 
(Grabenstein et al., 2004; Macfarlane et al., 2000; Miller et al., 1989; Moss et al., 
2000; Oyston et al., 2000; Pérez et al., 2001). In S. enterica serovar Typhimurium it 
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was shown that a phoP deletion leads to an attenuation of virulence in mice (Galán 
and Curtiss, 1989; Miller et al., 1989). 
The sensor kinase PhoQ is a membrane spanning protein and recognizes low Mg2+- 
and Ca2+-concentrations, acidic pH and the presence of antimicrobial peptides and 
activates the response regulator PhoP by phosphorylation (Fig. 1.5) (García Véscovi 
et al., 1996; Grabenstein et al., 2004; Groisman, 2001; Véscovi et al., 1997).  
 
 
Fig. 1.5 Schematic overview of the PhoP/PhoQ two component system.  
The sensor kinase PhoQ senses low Mg2+- and low Ca2+-concentrations as well as low pH and 
antimicrobial peptides. Thereby it activates the response regulator PhoP by phosphorylation. PhoP 
acts as transcriptional regulator and controls expression of target genes (modified from Groisman, 
2001). 
 
PhoP binds to PhoP box-like DNA sequences which are direct repeats of the 
sequence motif T/GGTTTAA/T leading to activation or repression of target gene 
expression (Lejona et al., 2003; Minagawa et al., 2003). For instance mgtA and 
mgtCB, encoding Mg2+-uptake systems, are activated by PhoP in S. enterica serovar 
low Mg2+, low Ca2+, acidic pH,
antimicrobial peptides
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Typhimurium (García Véscovi et al., 1996; Tao et al., 1995). Resistance to 
antimicrobial peptides is mediated by modifications of lipopolysaccharides (LPS), e.g. 
by activation of the synthesis of PagP, which incorporates palmitate into lipid A of the 
LPS (Guo et al., 1998). Furthermore, in S. enterica serovar Typhimurium PhoP 
activates the synthesis of PmrD, which leads to pmrAB expression. pmrAB encodes 
for another two-component system, PmrA/PmrB, that additionally promotes 
resistance against antimicrobial peptides (Gunn and Miller, 1996; Roland et al., 
1993). PhoP also regulates the expression of global virulence regulators such as 
RovA in Y. pestis and SlyA in S. enterica serovar Typhimurium. While PhoP activates 
expression of slyA in S. enterica serovar Typhimurium, expression of rovA in 
Y. pestis is repressed by PhoP (Norte et al., 2003; Zhang et al., 2011). Expression of 
the phoPQ operon itself occurs from two different promoters, one that is constitutively 
expressed and another that is positively autoregulated by PhoP/PhoQ (Kato et al., 
1999; Soncini et al., 1995).  
  
1.4.2 The carbon storage regulator system 
The carbon storage regulator (Csr) system is composed of the two small regulatory 
RNAs CsrB and CsrC and the dimeric RNA-binding protein CsrA (Heroven et al., 
2008; Romeo et al., 2013; Vakulskas et al., 2015). The Csr-system acts on post-
transcriptional level and is widely distributed among eubacteria including S. enterica 
serovar Typhimurium, Y. pseudotuberculosis, V. cholerae and E. coli (Altier et al., 
2000; Heroven et al., 2008; Lenz et al., 2005; Romeo et al., 1993; White et al., 1996). 
CsrA is a homodimer, each monomer comprises five β-strands, a small α-helix and a 
flexible C-terminus (Gutiérrez et al., 2005). CsrA binds preferably to GGA-motifs, 
which are often located in the RBS of target mRNAs. This blocks binding of 
ribosomes and thereby translation of mRNAs and leads to faster mRNA degradation 
by RNases (Babitzke et al., 2009; Dubey, 2005; Dubey et al., 2003). The small 
regulatory RNAs CsrB and CsrC harbor 18 and 14 GGA-motifs in 
Y. pseudotuberculosis, respectively, and antagonize the function of CsrA by direct 
sequestration, which leads to de-repression of target mRNA translation (Heroven et 
al., 2008; Liu et al., 1997; Romeo, 1998). Vice versa, the small RNAs require CsrA 
for stabilisation (Böhme, K., PhD thesis; Reimmann et al., 2005). Furthermore, the 
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two small RNAs are counter-regulated. Up-regulation of one RNA leads to down-
regulation of the other (Fig. 1.6) (Heroven et al., 2012a).  
 
 
Fig. 1.6 Regulatory network of the carbon storage regulator system.  
The Csr-system consists of the two non-coding RNAs CsrB and CsrC and the RNA-binding protein 
CsrA. CsrB and CsrC are stabilized by CsrA through binding to several GGA-motifs, while the small 
RNAs sequester CsrA from their target mRNAs and thereby inhibit CsrA activity. The two small RNAs 
counter-regulate each other, a high amount of one RNA leads to a decrease of the other. CsrB is 
activated by the two-component system BarA/UvrY in response to so far unknown environmental 
signals and is negatively influenced by Crp (cAMP receptor protein). Crp also activates the expression 
of csrC. A high amount of the small RNAs CsrB or CsrC leads to sequestration of CsrA, which results 
in an up-regulation of rovA and thereby in a higher amount of invasin (dashed lines – indirect control, 
solid lines – direct control). 
 
The two-component system BarA/UvrY and its homologues are found in many Gram-
negative bacteria. They belong to the control circuit of the Csr-system with BarA as 
sensor kinase and UvrY as cognate response regulator (Pernestig et al., 2003; 
Suzuki et al., 2002). The inducing signal for BarA is mostly unknown, however in 
E. coli it was shown that formate, acetate, intermediates of the tricarboxylic acid cycle 
and short-chain fatty acids activate BarA (Chavez et al., 2010). In contrast to E. coli 
and Salmonella enterica serovar Typhimurium leads the activation of the two-
CsrC CsrB 
CsrA 
RovM 
BarA 
UvrY 
Crp 
RovA 
Invasin 
Nutrients 
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component system BarA/UvrY to an induced expression of CsrB but not CsrC in 
Y. pseudotuberculosis (Heroven et al., 2008).  
The dimeric protein Crp is implicated in the overall control of the Csr-system in 
Y. pseudotuberculosis by regulating the small RNAs CsrB and CsrC (Heroven et al., 
2012a). Crp is, together with cAMP, involved in the catabolite repression and 
regulates genes of the carbohydrate metabolism. Alternative sugars such as lactose 
are only catabolized in the absence of glucose, due to the repression of cAMP 
synthesis by glucose (Crasnier, 1996; Ishizuka et al., 1994; Zheng et al., 2004). It 
was shown that in Y. pseudotuberculosis Crp represses csrB expression indirectly 
through UvrY, while csrC expression is activated by Crp (Heroven et al., 2012a).  
The Csr-system controls expression of genes involved in metabolism - stationary 
phase genes are often down-regulated by CsrA while genes of the exponential phase 
are up-regulated (Romeo, 1998). Furthermore, the Csr-system is important for 
virulence gene expression in Y. pseudotuberculosis. CsrA represses expression of 
the primary colonization factor invasin indirectly via the LysR-type regulator RovM 
and the MarR-type regulator RovA (Heroven et al., 2008, 2012a; Nagel et al., 2001). 
 
1.4.3 MarR-type regulators 
The family of multiple antibiotic resistance regulator (MarR) of transcriptional 
regulators was named after the first identified MarR protein in E. coli, due to a 
multiple antibiotic resistance phenotype (Cohen et al., 1993a; George and Levy, 
1983). Members of this family are widespread and can be found in bacterial and 
archaeal genomes. MarR-type regulators are involved in the control of metabolism, 
virulence gene expression, stress responses and resistance against antibiotics (Ariza 
et al., 1994; Pérez-Rueda and Collado-Vides, 2001; Sulavik et al., 1995). In the plant 
pathogen Erwinia chrysanthemi, virulence gene expression is regulated by PecS, 
which controls the expression of pectate lyase, cellulase as well as indigoidine 
(Reverchon et al., 1994, 2002). In Vibrio cholera AphA is important for the activation 
of the toxin-coregulated pilus, which is necessary for the intestinal colonization of the 
host (Kovacikova et al., 2004; Skorupski and Taylor, 1999; Taylor et al., 1987). MgrA 
of Staphylococcus aureus was found to regulate the expression of the type 8 
capsular polysaccharide, protein A, nuclease, alpha-toxin and coagulase (Luong et 
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al., 2003). Further members of the MarR-family involved in regulation of virulence 
gene expression are SlyA of S. enterica serovar Typhimurium and RovA of 
Y. pseudotuberculosis (Libby et al., 1994; Nagel et al., 2001). 
The first crystal structure of a MarR-type regulator revealed that this regulator family 
consist of six α-helices and three β-sheets and bind as homodimer to the DNA via a 
winged helix-turn-helix motif (Alekshun et al., 2001). It was described for many MarR-
homologues that DNA-binding is influenced by recognition of small anionic lipophilic 
molecules such as salicylate and related compounds (Wilkinson and Grove, 2006). In 
most cases, recognition of the small ligands attenuates binding to DNA through an 
overlap of DNA- and ligand-binding sites, e.g. for PecS of Erwinia and HucR of 
Deinococcus radiodurans which binds urate (Perera and Grove, 2010; Perera et al., 
2009; Wilkinson and Grove, 2004).  
Many of the MarR-type regulators act as repressor and activator of target genes as 
described for PecS of E. chrysanthemi and RovA of Y. pseudotuberculosis (Heroven 
et al., 2004; Nagel et al., 2001; Nasser et al., 1999; Praillet et al., 1996; Reverchon et 
al., 1994). 
 
1.4.3.1 RovA of Y. pseudotuberculosis 
All three pathogenic Yersinia species encode the transcriptional regulator RovA. The 
first discovery of RovA was in Y. enterocolitica in 2000 as a regulator of the early-
stage virulence factor invasin, which is important for the primary colonization of the 
host (Revell and Miller, 2000). RovA was identified to also control invA expression in 
Y. pseudotuberculosis (Nagel et al., 2001). It activates invA expression at moderate 
temperatures by interaction with two distinct binding sites 50 – 207 bp upstream of 
the transcriptional start site (Heroven et al., 2004; Nagel et al., 2001). In Y. pestis, 
RovA was found to regulate psaA expression, which encodes the pH 6 antigen, 
which is important for the development of bubonic plague (Cathelyn et al., 2006; 
Lindler et al., 1990). A rovA knock-out mutant of all of the pathogenic Yersinia 
species has a significantly higher LD50 value than the respective wild-type strain 
(Cathelyn et al., 2006; Heroven and Dersch, 2006; Revell and Miller, 2002). In 
contrast, the LD50 of an inv knock-out mutant is comparable to that of the wild-type 
strain indicating that RovA controls more virulence factors apart from invasin and has 
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a higher impact on the virulence of Yersinia (Pepe and Miller, 1993; Revell and Miller, 
2002). 
RovA consists of six α-helices and two β-sheets, and binds as homodimer via a 
winked helix-turn-helix motif to the DNA, similar to other MarR-type regulators 
(Alekshun et al., 2001; Quade et al., 2012). The activation of target genes occurs by 
direct interaction with the RNA-polymerase (RNAP) (Tran et al., 2005). The N-
terminus of RovA was identified to be important for DNA-binding while the C-terminus 
is involved in dimerization (Fig. 1.7) (Quade et al., 2012; Tran et al., 2005).  
 
 
Fig. 1.7 Structure of RovA.  
RovA forms a homodimer, each monomer consists of six α-helices and two β-sheets. The monomers 
are highlighted in blue and red (modified from Quade et al., 2012). 
 
The expression of rovA itself is auto-regulated. This has been also described for 
several other MarR-type regulators such as SlyA of S. typhimurium (Heroven et al., 
2004; Nagel et al., 2001; Stapleton et al., 2002). Expression occurs from two different 
promoters P1 and P2, which are located 76 and 343 nucleotides upstream of the 
transcriptional start site, respectively (Heroven et al., 2004). Binding of RovA 
upstream of promoter P2 results in activation of rovA expression, while binding 
downstream of promoter P1 leads to repression of rovA expression (Heroven et al., 
2004; Nagel et al., 2001). Furthermore, competitive electrophoretic mobility shift 
assays revealed a higher affinity of RovA to the upstream region of promoter P2. This 
DNA-binding 
domain
Dimerization 
domain
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suggests that RovA binds the low affinity site downstream of promoter P1 only when 
a certain threshold of RovA molecules is reached in the cell (Heroven et al., 2004).  
In addition to the positive and negative autoregulation, rovA expression is repressed 
by the nucleoid-associated protein H-NS (Heroven et al., 2004). The binding site of 
H-NS overlaps with the RovA binding site upstream of promoter P2 with a higher 
affinity to RovA than to H-NS. This indicates that H-NS represses rovA expression 
only in the absence of RovA and that RovA acts as anti-repressor (Heroven et al., 
2004; Tran et al., 2005).  
Moreover, rovA expression is dependent on the nutrient availability, which is 
mediated via the transcriptional regulator RovM. RovM belongs to the family of LysR-
type proteins and represses rovA expression by binding upstream of promoter P1. 
This effect is predominant when Y. pseudotuberculosis is grown in minimal media, 
due to a higher amount of RovM in the cell (Heroven and Dersch, 2006; Nagel et al., 
2001). RovM is indirectly activated by CsrA, which links the RovM-RovA-InvA 
cascade with the Csr-system (Heroven et al., 2008). 
Additionally, RovA synthesis is dependent on temperature. At moderate 
temperatures (20-28°C) rovA expression is activated, whereas expression is 
repressed at 37°C (Herbst et al., 2009; Nagel et al., 2001). RovA is a thermosensor; 
during a temperature shift, it undergoes a reversible conformational change, which 
alters the DNA-binding capacity. At 37°C the DNA binding affinity of RovA is reduced 
and amino acids, which are recognized by proteases are no longer protected through 
DNA-binding (Herbst et al., 2009). This renders RovA more susceptible to 
degradation by Lon and ClpP proteases at 37°C. Moreover, the expression of lon is 
increased at 37°C, which has an additional effect on the degradation of RovA (Herbst 
et al., 2009). Comparative studies of RovA and its homolog SlyA of S. enterica 
serovar Typhimurium revealed that a flexible loop between α-helix five and six is 
responsible for thermosensing activity of RovA (Quade et al., 2012). SlyA shares an 
amino acid sequence identity to RovA of 79%, but is stable at 37°C and does not act 
as a thermometer (Dolan et al., 2011; Quade et al., 2012). In this specific loop, RovA 
harbors a glycine at position 116, while SlyA harbors an alanine. An exchange of 
G116A in RovA results in the loss of the thermo-sensing activity and a higher DNA-
binding affinity at 37°C (Fig. 1.8) (Quade et al., 2012). 
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Fig. 1.8 Regulation of RovA.  
At 25°C RovA binds to a high-affinity site upstream of promoter P2 and activates its own expression. 
After the RovA amounts reach a certain threshold in the cell, RovA also binds to a low affinity site 
downstream of promoter P1 and inhibits its own expression. Additionally, RovM represses rovA 
expression when nutrient availability is low by binding upstream of promoter P1. At 37°C RovA 
undergoes a conformational change, which results in a loss of the DNA-binding capacity and 
increased degradation by proteases. Moreover, rovA is repressed by H-NS (modified from Herbst et 
al., 2009). 
 
Expression analysis and stability assays of RovA at different temperatures and 
growth phases revealed that RovA is stabilized during stationary phase and activates 
its own expression even at 37°C (Herbst et al., 2009; Nagel et al., 2001). The 
supernatant of stationary phase cells harbors a factor that stabilizes RovA (Herbst, 
K., PhD thesis; Mendonca, C., PhD thesis). Binding of small ligands to MarR-type 
regulators is well known (Perera and Grove, 2010; Wilkinson and Grove, 2004). 
Indeed, it could be shown that RovA binds several diverse ligands (Mendonca, C., 
PhD thesis). However, it remains unclear whether these ligands are the natural 
substrates of RovA. 
Taken together, rovA is maximally expressed at moderate temperatures, when grown 
in complex media. It is strongly auto-regulated and harbors an intrinsic thermosensor, 
which allows fast recognition of temperature changes and rapid adaption of target 
gene expression.  
 
1.5 Phenotypic heterogeneity  
For a long time it was assumed that the expression of a certain gene is unimodal 
under defined conditions. The steadily improving technologies for the analysis of 
single cells, like flow cytometry and fluorescence microscopy, now allow an 
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investigation of individual cells in a comparative approach. It became evident that 
genetically identical cells - grown under the same conditions - can develop and 
behave differently, which give rise to phenotypic heterogeneity of a population. The 
main source of phenotypic heterogeneity are stochastic fluctuations in gene 
expression, but also epigenetic modifications such as DNA methylation can lead to 
phenotypic heterogeneity (Casadesús and Low, 2006, 2013; Elowitz et al., 2002). 
Another origin of phenotypic heterogeneity might be cell ageing, e.g. in 
Methylobacterium extorquens cell size and timing of cell division depend on the pole 
age of a cell. Thereby, the cellular age contributes to phenotypic variability 
(Bergmiller and Ackermann, 2011).  
Phenotypic heterogeneity is a form of bet-hedging and beneficial in fast changing 
environments, in which the regulation of gene expression is too slow to ensure rapid 
adaptation to new conditions. One part of the population is pre-adapted to new 
conditions, which increases the fitness of the whole population (Ackermann, 2015; 
Veening et al., 2008a). The formation of persister cells is a well-described example of 
bet-hedging and phenotypic heterogeneity. Persister cells are very slow growing or 
non-growing cells, which are tolerant to antibiotics. After removing the antibiotic, 
persisters are able to regrow and form a new population consisting of antibiotic-
sensitive cells and persister cells (Lewis, 2007). In E. coli the toxin HipA is involved in 
the formation of persister cells (Moyed and Bertrand, 1983). If HipA exceeds a 
certain threshold, the cell become dormant and thereby resistant to antibiotics 
(Rotem et al., 2010). 
The division of labor between individual cells is another advantage of phenotypic 
heterogeneity (Ackermann, 2015). For instance, under nutrient-limiting conditions 
some B. subtilis cells synthesize and secrete the exoproteases bacillopeptidase and 
subtilisin E and thereby supply the enzyme to the whole population (Veening et al., 
2008b). This is also an example for social behavior of bacteria as one subpopulation 
takes over the costs for the production of exoenzymes, whereas the entire population 
benefits from these exoenzymes (Veening et al., 2008a). Social interactions between 
cells of one population are common for phenotypic heterogeneity. For example, in 
cyanobacteria nitrogen fixation and photosynthetic carbon fixation are separated into 
different cells types, but each cell type provides carbon or nitrogen to the other cell 
type, respectively (Reuven and Eldar, 2011). An extreme form of division of labor is 
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self-destructive cooperation as it is described for the heterogeneous expression of 
genes encoding for the T3SS-1 of S. enterica serovar Typhimurium (Ackermann et 
al., 2008). Cells, that express the t3ss-1 are impaired in growth and mainly killed by 
the host-immune system during invasion of the epithelium, while the other part of the 
population is fast growing and benefits from the inflammation by outcompeting the 
commensals in the gut (Ackermann et al., 2008; Diard et al., 2013; Sturm et al., 
2011). Moreover, the bistable expression of the t3ss-1 is also an example for bet-
hedging as the slow-growing T3SS-1-positive subpopulation is more tolerant to 
antibiotics and thereby promotes survival during exposure to antibiotics (Arnoldini et 
al., 2014) 
The heterogeneous expression of the T3SS-1 in S. enterica serovar Typhimurium 
gives evidence that phenotypic heterogeneity also contributes to virulence of 
bacteria. Several other examples of heterogeneous expression of virulence factors 
are described, e.g. expression of flagella genes in S. enterica serovar Typhimurium 
(Casadesús and Low, 2013; Zieg et al., 1977). Two different flagella genes are 
located in the genome of S. enterica serovar Typhimurium and due to the reversible 
inversion of a DNA fragment one or the other type of flagella is expressed. The 
regulated expression of two different flagella genes is believed to avoid recognition 
by the host immune system (Rossez et al., 2015; Zieg et al., 1977).  
 
1.5.1 Bistability  
A special kind of heterogeneity is bistability, which is characterized by the bifurcation 
of one bacterial population into two or more distinct subpopulations without any 
mutations or DNA-rarrangements (Dubnau and Losick, 2006; Graumann, 2006). 
Requirements for bistable expression of a gene are positive or double negative 
feedback loops together with a non-linear response in the regulatory network of a 
transcriptional regulator (Casadesús and Low, 2013; Ferrell, 2002; Smits et al., 
2006). In biological systems gene expression is subjected to random fluctuations – 
noise. Noise, amplified by a positive or double negative feedback loop can lead to 
expression of a certain gene in some cells, whereas other cells do not reach the 
threshold and gene expression is “OFF” (Elowitz et al., 2002; Ozbudak et al., 2002).  
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In Bacillus subtilis for example bistable expression is well described for the 
development of competence under limiting nutrient conditions, which arises in 10% - 
20% of all cells in stationary phase (Cahn and Fox, 1968; Graumann, 2006; Hadden 
and Nester, 1968). Responsible for the bistability is the positive feedback loop of the 
transcriptional activator ComK, which leads to expression of competence genes such 
as the DNA-uptake apparatus (Gamba et al., 2015; Maamar and Dubnau, 2005; van 
Sinderen et al., 1995). 
Besides competence, genes related to swimming and chaining are also 
heterogeneously expressed in B. subtilis. In an exponentially growing culture some 
cells are motile, while others do not separate after cell division and develop long 
chains (Dubnau and Losick, 2006; Kearns and Losick, 2005). The alternative sigma 
factor σD regulates motility as it is active in motile cells and inactive in sessile cells. 
The alternative sigma factor is responsible for the bifurcation of the culture in the two 
subpopulations (Cozy et al., 2012; Kearns and Losick, 2005).  
However, bistability is not a phenomenon restricted to bacteria, it is also described 
for eukaryotes and viruses. Bacteriophage λ reveals bistability during infection of 
E. coli. The virus can undergo the lytic pathway and thereby release phage particles 
or integrate DNA into the host genome by using the lysogenic pathway (Casjens and 
Hendrix, 2015). The decision which part of λ-infected cells will be lysed depends on 
the number of co-infecting phages and the two transcriptional regulators Cro and CI 
(Joh and Weitz, 2011; Smits et al., 2006). Bistability was also reported during 
maturation of Xenopus laevis oocytes. The inducing signal for maturation is the 
steroid hormone progesterone, which activates the Mos-MEK-MAP kinase cascade. 
A positive feedback loop within this cascade is responsible for the bistable maturation 
phenotype (Ferrell, 1999, 2002). 
The transcriptional regulator RovA of Y. pseudotuberculosis is a perfect candidate for 
bistable expression as it is positively and negatively auto-regulated. Additionally, a 
non-linear response is formed through cooperative binding of RovA to its own 
promoter region and enhanced proteolytic degradation at higher temperatures. 
Indeed, first experimental investigations revealed a temperature-dependent bistable 
expression of rovA (Herbst, K., PhD thesis; Nuss A. M., unpublished data). At 
moderate temperature (25°C) the entire population expresses rovA, while at higher 
temperature (37°C) no rovA expression was observed. However, at intermediate 
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temperature (32°C) two subpopulations with either high or low rovA expression were 
described and revealed bistability (Herbst, K., PhD thesis; Nuss A. M., unpublished 
data). 
 
1.6 Aim of this study 
The overall goal of this study is to investigate the molecular mechanisms underlying 
bistable expression of rovA of Y. pseudotuberculosis and the identification of its 
function during infection.  
RovA is a transcriptional regulator of early-stage virulence factors such as invasin, 
which is important for the primary colonization of the host (Nagel et al., 2001). 
Preliminary data revealed a temperature-dependent bistable expression of the 
transcriptional regulator RovA of Y. pseudotuberculosis (Herbst, K., PhD thesis, 
Nuss, A. M., unpublished data). One aim of this thesis is to analyze the dynamics of 
bistable rovA expression. To address this aim, time-lapse microscopy, following the 
fate of one cell, will be established. In order to gain deeper information about the 
molecular mechanisms involved in the establishment of bistable rovA expression, the 
impact of elements implicated in thermosensing and proteolysis of RovA should be 
analyzed. For this purpose, mutants altering in RovA stability and thermosensing will 
be constructed and tested for bistable rovA expression. Moreover, possible strain-
specific differences in the bistable expression of rovA will be considered. Therefore, 
rovA expression will be analyzed in the two different clinical isolates YPIII and 
IP32953.  
As the role of heterogeneity of RovA on virulence of Y. pseudotuberculosis is 
unknown, the impact of bistable rovA expression during the infectious process should 
be investigated. First, the expression of rovA within organs as well as their spatial 
distribution will be explored. Next, the impact of bistable rovA expression on virulence 
of Y. pseudotuberculosis will be analyzed. Therefore, a ΔrovA mutant as well as 
mutants expressing stabilized RovA variants will be compared to the wild type with 
respect to organ colonization and survival of mice. 
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2 Materials and methods 
2.1 Materials 
2.1.1 Equipment and material 
The material and equipment used in this study were obtained from BD Biosciences, 
Biochrom, Biometra, Bio-Rad, Brand, Consort, Eppendorf, GE Healthcare, Gilson, 
Greiner, Heraeus, Heidolph, Hirschmann EM, Ibidi, Integra Biosciences, Janke & 
Kunkel IKA-Labortechnik, Laboport, Marienfeld, Millipore, Microflex Corporation, 
PeqLab, Roth, Sarstedt, Sartorius, Schott, Sigma Aldrich, Sorvall, TPP, Thermo 
Scientific, Oregon Scientific, VWR International, Whatman Schleicher & Schüll GmbH 
and Zeiss if not stated otherwise. 
 
2.1.2 Chemicals and buffers 
Chemicals were purchased from Applichem, BD Biosciences, Biochrom, Biolegend, 
BioMoll, BioXCell, Difco, eBioscience, Fermentas, Fischer Scientific, Fluka, GIBCO, 
Invitrogen, Jackson ImmunoResearch, J.T. Baker, Life Technologies, Merck, 
Metabion, New England Biolabs Inc. (NEB), PAA, Pierce, Perkin Elmer, PeqLab, 
Promega, PromoCell, Qiagen, Roche, Roth, Sigma Aldrich, Serva, T.H. Geyer and 
Zeiss if not stated otherwise. The composition of buffers and solutions is listed in 
Table 2.1. 
 
Table 2.1 Composition of buffers and solutions. 
Buffer/solution Composition 
Binding buffer 20 mM NaH2PO4, 100 mM KCl, 5% glycerol, 
2 mM 1,4-dithiothreitol, pH 8.0 
Coomassie staining solution 20% isopropanol, 10% acetic acid, 0.05% 
CoomassieTM Brilliant Blue G250 
Lysis buffer for proteins 50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazol, pH 8.0 
Lysis buffer for RNA 0.01 M NaOAc pH 4.5, 2% SDS 
20x MOPS buffer 200 mM MOPS, 50 mM sodium acetate, 
10 mM EDTA 
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Buffer/solution Composition 
PBS 8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 
0.24 g/l KH2PO3-, pH 7.4 
Elution buffer 50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazol, pH 8.0 
RNA-resuspension buffer 0.3 M sucrose, 0.01 M NaOAc pH 4.5 
SDS running buffer 33 mM Tris-HCl pH 8.3, 192 mM glycine, 
0,1% SDS 
SDS sample buffer 0.1 M Tris pH 6.8, 40% glycerol, 10% β-
mercaptoethanol, 3.2% SDS, 0.2% 
bromophenol blue 
Seperating gel buffer 500 mM Tris-HCl, 4% SDS, pH 6.8 
20x SSC buffer 3 M NaCl, 0.3 M sodium citrate, pH 7.0 
Stacking gel buffer 1.5 M Tris-HCl, 4% SDS, pH 8.8 
50x TAE (Tris-acetate-EDTA) buffer  2 M Tris-HCl pH 8.3, 1 M acetic acid, 0.1 M 
EDTA 
10x TBE (Tris-borate-EDTA) buffer 900 mM Tris-HCl, 900 mM boric acid, 25 mM 
EDTA pH 8.0 
TBST buffer 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% 
Tween-20 
TFBI-buffer 30 mM KAc, 10 mM CaCl2, 50 mM MnCl2, 
100 mM RbCl, 15% glycerol, pH 5.8  
TFBII-buffer 10 mM PIPES, 75 mM CaCl2, 10 mM RbCl, 
15% glycerol, pH 6.5 
Transblot buffer 25 mM Tris, 192 mM glycine, 20% methanol 
Transformation buffer 272 mM sucrose, 15% glycerol 
Washing buffer 50 mM NaH2PO4, 300 mM NaCl, 20 mM 
imidazol, pH 8.0 
Z-buffer 100 mM sodium phosphate buffer pH 7.0, 
1 mM MgSO4 
 
2.1.3 Media  
The media used in this study were prepared with distilled water and are listed in 
Table 2.2. 
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Table 2.2 Media. 
Media Composition 
BHI broth (brain-heart infusion) 37 g/l BHI 
LB broth (Sambrock et al., 1989) 5 g/l yeast extract, 5 g/l NaCl, 10 g/l tryptone 
LB solid medium LB-medium, 18 g/l agar 
SOC medium (super optimal 
broth) 
5 g/l yeast extract, 0.5 g/l NaCl, 20 g/l tryptone, 
2.5 ml/l 1 M KCl, 10 ml/l 1 M MgCl2, 10 m/l 1 M 
MgSO4 
Yersinia solid medium Yersinia selective agar base and Yersinia 
selective supplement (Oxoid) 
 
2.1.4 Enzymes, antibodies and kits 
Enzymes applied with provided buffers and antibodies used in this study are listed in 
Table 2.3. The primary antibodies anti-RovA and anti-HNS are polyclonal antibodies 
produced in rabbits, the primary antibody anti-InvA is monoclonal and produced in 
mice. 
 
Table 2.3 Enzymes and antibodies. 
Enzymes/ Antibody (dilution) Manufacturer 
Enzyme  
Antarctic phosphatase NEB 
DNase I Roche 
MangoTaqTM DNA polymerase Bioline 
PfuUltra II Fusion HS DNA polymerase Agilent 
Phusion® High-Fidelity DNA polymerase NEB 
Restriction enzymes NEB 
T4 DNA ligase NEB 
Taq DNA polymerase NEB 
Antibody (dilution and buffer)  
Anti-HNS (1:1000 000 in TBST + 3% BSA) Davids Biotechnology 
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Enzymes/ Antibody (dilution) Manufacturer 
Anti-InvA 3A2 (1:4000 in TBST + 5% skim milk 
powder) 
Dersch and Isberg, 1999 
Anti-RovA (1:4000 in TBST + 3% BSA) Davids Biotechnology 
Anti-RovM (1:4000 in TBST + 3% BSA) Davids Biotechnology 
Anti-rabbit-HRP (1:7000 in TBST + 3% BSA) NEB 
Anti-mouse-HRP (1:7000 in TBST + 5% skim milk 
powder) 
NEB 
 
 
Commercial kits used in this study are listed in Table 2.4.  
 
Table 2.4 Kits. 
Kit Application Manufacturer 
Coomassie Reagent Protein 
Assay Kit 
Determination of protein 
concentration 
Pierce 
DIG Luminescent Detection Kit  Detection of DIG-labeled probes Roche 
QIAprep® Spin Miniprep Kit Preparation of plasmid DNA Qiagen 
QIAquick® Gel Extraction Kit Extraction of DNA from agarose 
gels 
Qiagen 
QIAquick® PCR Purfication Kit Purification of PCR products Qiagen 
SV total RNA Purification Kit Purification of RNA Promega 
Western Lightning ECL II Kit Detection of secondary 
antibodies (HRP) for Western 
blotting  
Perkin Elmer 
 
2.1.5 Oligonucleotides 
Oligonucleotides used in this study were purchased from Metabion in a concentration 
of 100 µM. For PCR reactions the primer concentration was diluted to 10 µM (Table 
2.5).  
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Table 2.5 Primer.
 Name Sequence 5' - 3' Description 
135 GCGGCGGTCGACCAACGTAGT
CGGTGCCATCGG 
sequencing primer for chromosomal 
integration of rovA 
151 GCGGCGTCTAGATATATTATCT
ACATCCATCTGGC 
sequencing primer for chromosomal 
integration of rovA 
555 CGGCGCGGATCCCTCTCACAC
CAGCTGTG 
sense primer of csrB for Northern 
blotting 
556 GGGGGCGTCGACGGCAAACT
CAATATCCTG 
anti-sense primer of csrB for Northern 
blotting 
582 GCGGCGGTCGACCCTTCATCC
CGTGGTAGG 
sense primer of csrC for Northern 
blotting 
583 GGGCGCGGATCCGATTGGGC
CGGAATCTAGC 
anti-sense primer of csrC for Northern 
blotting 
I79 GTCGTCTCCGTTAGAGATTAC sense primer of csrC for footprint 
I293 GCTCCGTTTATAGCGTCCTTG DIG-labeled sense primer of csrC for 
footprint 
II379  AACGGAACAGTCTTCATCGATA
ATCGAACAGGT 
sense primer for RovA Quick-Change 
of P98S, creates codon CCG  TCG 
II380 ACCTGTTCGATTATCGATGAAG
ACTGTTCCGTT 
anti-sense primer for RovA Quick-
Change of P98S, creates codon CCG 
 TCG 
II480 GCGGGTCGACTCCCTATCAGT
GATAGAGATTGACATCCCTATC
AGTGATAGAGATACTGAGCA 
CAAAGGAGGAGCAATTGGAAT
CG 
sense primer for Ptet-rovA, creates SalI 
site 
II483 GCGCGCGGCCGCTTATTACTT
AGTTTGTAATTG 
anti- sense primer of rovA coding 
region, creates NotI site 
II525 GCGCGCGCGGCCGCTTAAGC
TACTAAAGCGTAGTTTTCGTCG
TTTGCTGCTTTGTATAGTTCAT
CCATGCCATG 
anti-sense primer for egfpLVA, creates 
NotI site 
II624 GCAAAGAAATACTTGCGGGGA
TTTCATCGG 
sense primer for RovA Quick-Change 
of G116A creates codons GGG 
GCG 
II625 CCGATGAAATCCCCGCAAGTA
TTTCTTTGC 
anti-sense primer for RovA Quick-
Change of G116A creates codons 
GGG GCG 
II626 GATGAAATTGCAGTGTTAATAA
AGCTAATCGATAAGC 
sense primer for RovA Quick-Change 
of SG127128IK creates codons 
TCAGGC ATAAAG 
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 Name Sequence 5' - 3' Description 
II627 GCTTATCGATTAGCTTTATTAA
CACTGCAATTTCATC 
anti-sense primer for RovA Quick-
Change of SG127/128IK creates 
codons TCAGGC ATAAAG 
III186 TGTAGTCGGGGACGTTATCG sense primer of gyrA for EMSA 
III187 CCCATCCACCAGCATATAGC anti-sense primer of gyrA for EMSA 
III784 GCGGCGGCATGCGCAAGGCG
TTCAGGGAGC 
anti-sense primer for rovA 
amplification, creates SphI site 
III947 GCGGTCGACGGCGTGCTAAC
GACAATGAC 
sense primer for rovA amplification, 
creates SalI site 
IV483 GCGGGTCGACAAAGGAGGAG
CAATTGGAATCG 
sense primer for rovA-egfpLVA 
translational fusion, creates SalI site 
IV490 GCGGGACGTCGCTAACACAGC
G GTGGCCTCAAG 
sense primer for amplification of rho 
promoter, creates AatII site 
IV491 GCGGGTCGACGGGTATGTCTT
GAACTATGGTCGTG 
anti-sense primer for amplification of 
rho promoter, creates SalI site 
IV937 GATAGTTATAGTTTCTGATGGT
C 
sense primer of csrC for EMSAs 
IV938 GGGCTATTATGCACAGCTCTC sense primer of csrC for EMSAs 
IV939 ATCCATTACGTTCCTTGTATAT
C 
anti-sense primer of csrC for EMSAs 
IV940 GAGAGCTGTGCATAATAGCCC anti-sense primer of csrC for EMSAs 
V519 GGGCGCGAGCTCCAGGAGTC
CAAGCGAGCTC 
sense primer of chloramphenicol 
cassette, creates SacI site 
V520 GGGCGCGACGTCGATCACTAC
CGGGCG 
anti-sense primer of chloramphenicol 
cassette, creates AatII site 
V521 GGGCGCCCTAGGCGAATTGAG
GGGTACTGG 
sense primer of ori p15a, creates AvrII 
site 
V522 GGGCGCGAGCTCCCTCGCTCA
CTGACTCGC 
anti-sense primer of ori p15a, creates 
SacI site 
V586 GTCGTCTCCGTTAGAGATTAC DIG-labeled anti-sense primer of csrC     
for footprint 
V587 GCTCCGTTTATAGCGTCCTTG sense primer of csrC for footprint 
V842 GCGGGTCGACAAAATAAGGAGGA
AAAAAAAATGGTT 
sense primer of mCherry, creates SalI   
site 
V843 GCGGGCGGCCGCTTATTATTA
TTTGTACAGCTCATCCAT 
 
anti-sense primer of mCherry, creates 
NotI site 
The corresponding restriction sites are underlined, introduction of base pair substitutions for 
mutagenesis are shown in bold letters. 
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2.1.6 Strains and Plasmids 
Plasmids used in this study are listed in Table 2.6, E. coli and Y. pseudotuberculosis 
strains are listed in Table 2.7. 
 
Table 2.6 Plasmids. 
Plasmids Description Source and reference 
pAKH3 sacB+, AmpR Nagel et al., 2001 
pAKH101 pHT124, csrB-lacZ(4)a, AmpR Heroven et al., 2008 
pAKH103 pHT124, csrC-lacZ(4)a, AmpR Nuss and Schuster et 
al., 2014 
pAKH120 tet-crsB, ori p15a, CmR Heroven AK. 
pAKH139 pFU67, crp-lacZ(1)b, AmpR Nuss and Schuster et 
al., 2014 
pAKH188 pFS31, csrCYPIII+20nt IP32953, AmpR Nuss and Schuster et 
al., 2014 
pCM33 rovA-lacZ(1)b, ori pSC101*, KanR Mendonca, C. 
pDM4 R6K derivative, sacB+, CmR Böhme et al., 2012 
pET28a T7 promoter based expression vector, KanR Novagen 
pFS1 pDM4, rovA+YPIII, CmR This study 
pFS5 pKH70, Prho-egfpLVA, AmpR This study 
pFS6 pJet1.2, rovA+YPIII, AmpR This study 
pFS7 pFS6, rovAP98S, AmpR This study 
pFS8 pDM4, rovAP98S, CmR This study 
pFS13 pET28a, phoP+, KanR Nuss and Schuster et 
al., 2014 
pFS14 pFS6, rovAG116A, AmpR This study 
pFS15 pFS6, rovASG127/128IK, AmpR This study 
pFS16 pDM4 rovAG116A, CmR This study 
pFS17 pDM4, rovASG127/128IK, CmR This study 
pFS21 pFS7, rovAP98S, SG127/128IK, AmpR This study 
pFS22 pFS14, rovAG116A, SG127/128IK, AmpR This study 
pFS23 pFS7, rovAP98S, G116A, AmpR This study 
pFS24 pFS23, rovAP98S, G116A, SG127/128IK, AmpR This study 
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Plasmids Description Source and reference 
pFS25 pDM4, rovAP98S, SG127/128IK, CmR This study 
pFS26 pDM4, rovAG116A, SG127/128IK, CmR This study 
pFS27 pDM4, rovAP98S, G116A, CmR This study 
pFS28 pDM4, rovAP98S, G116A, SG127/128IK, CmR This study 
pFS29 pAKH3, csrCIP32953, AmpR Nuss and Schuster et 
al., 2014 
pFS30 pAKH3, csrCIP32953–20 nt, AmpR Nuss and Schuster et 
al., 2014 
pFS31 pAKH3, csrCYPIII, AmpR Nuss and Schuster et 
al., 2014 
pFS42 pZE21, PLtetO-1-dsRed2, KanR This study 
pFS43 pFS42, PLtetO-1-mCherry, KanR This study 
pFS46 pFU69, tet-rovAP98S, G116A, SG127/128IK, KanR This study 
pFS48 pFS43, ori p15a, CmR This study 
pFU69 promoterless egfp, colE1, KanR Uliczka et al., 2011 
pFU76 promoterless dsRed2, ori R6K, AmpR Uliczka F. 
pFU228 gapA-dsRed2, ori colE1, CmR Uliczka F. 
pHT124 promoter-probe vector, lacZ+, AmpR Heroven et al., 2008 
pJet1.2 cloning vector, AmpR Thermo Scientific 
pKB63 pTS02, csrA-lacZ(6)b, AmpR Nuss and Schuster et 
al., 2014 
pKH70 pFU76, ProvA-rovA-egfpLVA, AmpR, 
∆R6Kmob, ori29807, containing rovA 
promoter fragment from -622 to +170 
Herbst, K., PhD thesis 
pTB23 mCherry, attLambda, ori R6K, CmR Erhardt M. 
pTS02 promoterless lacZ, ori pSC101*, AmpR Nuss and Schuster et 
al., 2014 
pZE21 PLtetO-1, ori colE1, KanR Lutz and Bujard, 1997 
aThe number indicates the nucleotide of the corresponding gene fused to lacZ. bThe number indicates 
the codon of the corresponding gene fused to lacZ.  
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Table 2.7 Strains.
Strains Description Source and reference 
E. coli   
DH10ß F- endA1 recA1 galE15 galK16 nupG rpsL 
ΔlacX74 Φ80lacZΔM15 araD139Δ(ara, 
leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC)λ- 
Casadaban and Cohen, 
1980 
BL21λDE3 F- ompT gal dcm lon hsdSB (rB2 mB2) gal 
λDE3 
Studier and Moffatt, 
1986 
CC118 
λpir 
F- Δ(ara-leu)7697 Δ(lacZ)74 Δ(phoA)20 
araD139 galE galK thi rpsE rpoB arfEam 
recA1 
Manoil and Beckwith, 
1986 
S17-1λpir  recA1 thi pro hsdR- RP4-2Tc::Mu Km::Tn7 
λpir 
Simon et al., 1983 
Y. pseudotuberculosis 
IP32953 pIB1, wild type Chain et al., 2004 
YPIII pYV, wild type Bölin et al., 1982 
YP69 YPIII, ΔcsrB Heroven et al., 2008 
YP72 YPIII, ΔrovM Heroven et al., 2012a 
YP89 YPIII, Δcrp Heroven et al., 2012a 
YP107 YPIII, ΔrovA Quade et al., 2012 
YP126 YPIII, ΔcsrC Heroven et al., 2012a 
YP149 YPIII, phoPQIP32953 Schweer et al., 2013 
YP192 YP191, ΔinvA Geyer, R., PhD thesis 
YP268 YP107, rovA+YPIII This study 
YP269 YP107, rovAP98S This study 
YP270 YP107, rovAG116A This study 
YP271 YP107, rovASG127/128IK  This study 
YP279 YP107, rovAP98S, SG127/128IK This study 
YP285 YP149, ΔcsrC, KanR Nuss and Schuster et 
al., 2014 
YP286 YP107, rovAG116A, SG127/128IK This study 
YP287 YP107, rovAP98S, G116A, SG127/128IK This study 
YP288 YP107, rovAP98S, SG127/128IK This study 
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Strains Description Source and reference 
YP306 YP285, csrCYPIII+20nt IP32953 Nuss and Schuster et 
al., 2014 
YP307 YP285, csrCIP32953 Nuss and Schuster et 
al., 2014 
YP308 YP285, csrCYPIII Nuss and Schuster et 
al., 2014 
YPIP6 IP32953, phoPQYPIII Nuss and Schuster et 
al., 2014 
 
2.1.7 Software and databases 
Software used in this study was ApE (A plasmid Editor), FlowJo (Tree Star Inc.), 
FACSDivaTM (BD Bioscience), Graph Pad PRISM 5.0 (Graphpad Software, Inc.), 
ImageJ (National Institutes of Health, Wayne Rasband) and ZEN 2012 (Zeiss). The 
following databases were used: Bioinformatical information from databases National 
Center for Biotechnology Information (NCBI; www.ncbi.nlm.gov) and Kyoto 
Encyclopedia of Genes and Genomes (KEGG; www.genome.jp/kegg/). 
 
2.2 Methods 
2.2.1 Microbiological methods 
2.2.1.1  Cultivation and storage of bacteria 
Y. pseudotuberculosis strains were routinely grown under aerobic conditions in liquid 
LB media overnight to stationary growth phase or as day cultures for 3-4 hours to 
exponential growth phase at indicated temperatures. For solid cultivation on agar 
plates bacteria were incubated for two days at 25°C. E. coli strains were routinely 
grown in LB media for liquid cultivation overnight at 37°C or as day cultures for 3-5 
hours and on agar plates for solid cultivation at 37°C. If necessary, antibiotics were 
added at the following concentrations: ampicillin 100 µg ml-1 (Roth), chloramphenicol 
30 µg ml-1 (Roth) and kanamycin 50 µg ml-1 (Merck).  
Bacteria were frozen for long-term storage in 30% sterile glycerol at -80°C. 
  
Materials and methods  32 
 
2.2.1.2  Sterilization 
Solutions and media were heat sterilized in an autoclave for 20 min at 121°C with 
1 bar overpressure. Solutions that could not be autoclaved like antibiotics or sucrose 
were sterile filtered (pore diameter 0.2 µm). Heat sterilization was done for glassware 
at 180°C for 6 hours. 
 
2.2.1.3  Measurement of cell density 
The cell density of liquid cultures was monitored with a spectrophotometer 
(Amersham Biosciences) at a wavelength of 600 nm (OD600 nm).  
 
2.2.1.4  Flow cytometry analysis 
For flow cytometry overnight cultures grown at different temperatures between 25°C 
and 37°C were used for inoculation of a fresh culture. For this purpose, bacteria were 
diluted 1:50 in prewarmed media and incubated at the same temperature as the 
overnight culture. Bacteria were harvested in exponential growth phase by 
centrifugation (1 min, 14.000 g, room temperature). The pellets were resuspended 
with 1 ml 4% PFA (paraformaldehyde) and incubated for 20 min at room 
temperature. Cells were washed twice with 1 ml 1x PBS and stored in PBS in the 
fridge until further analysis in an LSR-II-Sorp flow cytometer (BS Bioscience). At least 
100.000 cells were measured. The data were acquired with FACS Diva software (BD 
Biosciences) and further analyzed with the software FlowJo v9.7.2 (Tree Star Inc.). 
 
2.2.1.5  Fluorescence microscopy and live cell imaging 
Fluorescence microscopy and live cell imaging was performed with an Axiovert II 
fluorescence microscope (Zeiss) using an Axiocam HR digital charge-coupled device 
(CCD) camera (Zeiss) and the software ZEN 2012 (Zeiss). For batch cultures 
bacteria were grown to exponential growth phase at indicated temperatures, 
harvested and fixed as described for flow cytometry (see 2.2.1.4), spotted onto a 
glass slide and examined under the microscope. To perform live cell imaging, 
bacteria were grown to exponential growth phase at 32°C, diluted 1:10 in LB medium 
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and grown on agar blocks of 1 mm diameter in a micro-Dish35mm (ibidi) under the 
microscope for up to 10 hours at the same temperature. Pictures were taken every 
15 min and the images further processed with the software ImageJ. 
 
2.2.2 Genetic and molecular biological methods for DNA 
2.2.2.1  Plasmid and genomic DNA preparation  
Plasmid DNA was isolated with the QIAprep Spin Miniprep Kit (Qiagen) according to 
the manufacturer’s instructions. Distilled water was used for elution of plasmid DNA. 
To isolate genomic DNA, 750 µl overnight culture were mixed carefully with one 
volume of phenol-chloroform-isoamylalcohol (25:24:1) and centrifuged (2 min, 
10.000 g, room temperature). The watery supernatant was transferred in a new tube 
and one volume of chloroform was added. The tube was inverted carefully and then 
centrifuged (2 min, 10.000 g, room temperature). Again, the watery supernatant was 
transferred in a new tube and DNA was precipitated by adding two volumes of pure 
ethanol. After centrifugation (20 min, 10.000 g, room temperature) the DNA pellet 
was washed twice with 70% ethanol and then air-dried. The DNA was resuspended 
in 100 µl TE-buffer (0.1 M Tric-HCl pH 7.5, 1 mM EDTA) and the concentration was 
measured photometrically with a NanoDrop spectrophotometer (PeqLab) at 260 nm. 
 
2.2.2.2  Polymerase chain reaction (PCR) 
Polymerase chain reaction was performed to amplify DNA fragments with heat stable 
DNA polymerases and specific primers. The annealing temperature is dependent on 
the primer length and sequence, whereas the elongation time and temperature 
depend on the polymerase and size of the amplified DNA fragment.  
The Phusion High-Fidelity DNA polymerase has a low error rate because of its proof 
reading activity and was therefore used for the amplification of DNA fragments that 
were further used for cloning or sequencing. Fragments for test-PCRs and colony-
PCRs were amplified with the MangoTaq polymerase. Site directed mutagenesis was 
performed with the PfuUltra II Fusion HS DNA polymerase. The Taq polymerase was 
used to amplify DNA fragments for EMSAs. The composition and reaction conditions 
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for PCR were performed in 50 µl or 100 µl volumes according to the manufacturer's 
instructions. 
 
2.2.2.3  Agarose gel electrophoresis 
For size estimation of DNA fragments agarose gel electrophoresis was performed. In 
an electric field the negatively charged DNA is separated by its size. Routinely, 0.8% 
[w/v] agarose TAE gels buffer were used. DNA samples were mixed with 6x loading 
dye (10 mM Tris-HCl, 0.03% bromophenol blue, 0.03% xylene cyanol, 60% glycerol, 
60 mM EDTA, pH 7.6) and electrophoresis was performed at 100 to 120 V. Gene 
Ruler DNA Ladder Mix (Thermo Scientific) was used as size standard (Fig. 2.1). DNA 
fragments were visualized by ethidium bromide, a DNA intercalating molecule, which 
is fluorescent upon UV-light exposure. Gel images were taken via a documentation 
system (BioRad). 
 
 
Fig. 2.1 Gene ruler DNA Ladder Mix (Thermo Scientific). 
 
2.2.2.4  DNA extraction and purification from agarose gels 
The QIAquick Gel Extraction Kit (Qiagen) was used for purification of DNA fragments 
from agarose gels according to the manufacturer’s instructions. Purified DNA 
fragments were eluted with distilled water. 
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2.2.2.5  Cloning techniques 
2.2.2.5.1 Restriction digestion 
For cloning of DNA fragments into plasmids and to proof the size of an insert 
restriction digestion was applied. Restriction enzymes recognize specific palindromic 
sequences and cut them in such a way that overhanging (sticky) or blunt ends are 
generated. The restriction enzymes were purchased from NEB and reaction 
conditions were used as described by the manufacturer. The enzymes were heat-
inactivated for 20 min at 65°C. 
 
2.2.2.5.2 Dephosphorylation of plasmids 
Dephosphorylation of plasmids was performed to remove phosphate groups at the 5’ 
end of plasmids after restriction digestion to reduce the religation rate of the vector. 
The Antarctic Phosphatase (NEB) was used according to the manufacturer’s 
description. The enzyme was heat-inactivated for 10 min at 65°C. 
 
2.2.2.5.3 Ligation 
The T4 DNA Ligase (NEB) was used to ligate plasmid and insert DNA. This enzyme 
catalyzes the formation of phosphodiester bonds between complementary sticky 
ends of the digested vector DNA and insert DNA. The ligation reaction was carried 
out in ligation buffer for 3-6 hours at room temperature or at 18°C overnight. The 
enzyme was heat-inactivated for 20 min at 65°C. 
 
2.2.2.6  DNA sequencing  
For quality control cloned and PCR amplified DNA was sequenced by the in house 
sequencing facility.  
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2.2.2.7  Transformation 
2.2.2.7.1 Preparation of chemocompetent E. coli strains 
E. coli cells were grown in LB medium containing 20 mM MgSO4 at 37°C for 3-5 
hours and centrifuged (10 min, 2.755 g, 4°C). The supernatant was discarded and 
the pellet was resuspended in 0.4 volumes of ice-cold TFBI-buffer. Cells were chilled 
on ice for about 10 min followed by centrifugation (10 min, 2.755 g, 4°C). The pellet 
was resuspended in 0.05 volume of ice-cold TFBII-buffer, chilled on ice for 15-60 min 
and aliquots of 50-100 µl were stored at -40°C till usage. 
 
2.2.2.7.2 Heat shock transformation of E. coli strains 
For transformation of plasmid DNA into chemocompetent E. coli strains, 50-100 µl of 
bacteria were incubated with an appropriate amount of plasmid DNA on ice for 
15 min. Then bacteria were transferred to 42°C for 60 sec and immediately diluted in 
1 ml SOC medium. Subsequently, the bacteria were incubated at 37°C for one hour, 
plated on solid medium with respective antibiotics and incubated overnight at 37°C. 
 
2.2.2.7.3 Preparation of electrocompetent Y. pseudotuberculosis strains 
Y. pseudotuberculosis cells were grown to exponential growth phase at 25°C in BHI 
medium. Bacteria were chilled on ice for 10-30 min and then centrifuged (15 min, 
2.755 g, 4°C). After resuspension of the pellet in 0.2 volume ice-cold distilled water, 
the cells were centrifuged (15 min, 2.755 g, 4°C) and the pellet was resuspended in 
0.2 volume ice-cold transformation buffer. After a further centrifugation step (15 min, 
2.755 g, 4°C) the cells were resuspended in a 1/500 volume of transformation buffer 
and immediately used for transformation. 
 
2.2.2.7.4 Electroporation 
For transformation of electrocompetent Y. pseudotuberculosis cells 50-80 µl of the 
bacteria were mixed with plasmid DNA, transferred into a glass cuvette and 
electroporated at 2.5 kV, 25 µF and 200 Ω (GenePulser II, BioRad). Immediately 
after electroporation 1 ml SOC medium was added. The bacteria were incubated at 
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25°C and 750 rpm for 2 hours and then incubated overnight on solid medium with 
antibiotics at 25°C. 
 
2.2.2.8  Construction of plasmids 
Construction of plasmid pFS1 was done by amplification of rovA from 
Y. pseudotuberculosis YPIII chromosomal DNA with primers III784/III947, digestion 
of the PCR product with SalI/SphI and ligation into pDM4.  
For the construction of pFS5 the promoter region of rho was amplified from 
Y. pseudotuberculosis YPIII chromosomal DNA with primers IV490/IV491 and cut 
with AatII/SalI. Furthermore, egfpLVA was amplified from plasmid pKH70 with primers 
II525/IV483 and cut with NotI/SalI. The plasmid pKH70 was cut with AatII/NotI and 
the two fragments rho and egfpLVA, were ligated into pKH70 resulting in plasmid 
pFS5.  
Construction of plasmid pFS6 was performed by amplification of rovA from 
Y. pseudotuberculosis YPIII with primers III947/III784, restriction with SalI/SphI and 
ligation into the cloning vector pJet (Thermo Scientific). Plasmids pFS8, pFS16, 
pFS17, pFS25, pFS26, pFS27 and pFS28 were constructed by restriction of rovA 
with SalI/SphI from pFS7, pFS14, pFS15, pFS21, pFS22, pFS23 and pFS24 and 
ligation into pDM4.  
In order produce RovAP98S, G116A, SG127/128IK under the control of the constitutive tet-
promoter, plasmid pFS46 was constructed by amplification of rovA from plasmid 
pFS28 with primers II480/II483, cut with SalI/NotI and ligated into pFU69.  
To construct a plasmid with constitutive Ptet-mCherry expression plasmid pFU76 was 
cut with KpnI/AvrII and ligated into pZE21 to obtain pFS42. mCherry was amplified 
from pTB23 with primers V842 and V843, cut with SalI/NotI and ligated into pFS42 
resulting in pFS43. For chloramphenicol resistance, the chloramphenicol cassette 
was amplified from pFU228 with primers V519/V520 and cut with AatII/SacI. The 
origin of replication p15a was amplified from pAKH120 with V521/V522, cut with 
AvrII/SacI and ligated together with the chloramphenicol cassette into pFS43, which 
resulted in pFS48. 
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2.2.2.9  Site directed mutagenesis 
For the integration of specific point mutations into a DNA sequence site directed 
mutagenesis was performed using the Quick-Change Site-directed Mutagenesis Kit 
(Stratagene). For this purpose, PCR was performed with the PfuUltra II Fusion HS 
DNA polymerase (Agilent) according to the manufacturer’s instructions. The PCR-
product was digested with DpnI, transformed into E. coli K-12 cells and plated on LB 
agar with appropriate antibiotics. The plasmids pFS7, pFS14 and pFS15 were 
constructed by Quick-Change mutagenesis of plasmid pFS6 with the primers 
II379/II380, II624/II625 and II626/II627, respectively. Quick-Change mutagenesis of 
pFS7 and pFS14 with primers II626/II627 resulted in plasmid pFS21 and pFS22, 
respectively. Plasmid pFS23 was constructed from plasmid pFS7 with primers 
II624/II625 and plasmid pFS24 was generated from plasmid pFS23 with primers 
II626/II627 using Quick-Change mutagenesis. 
 
2.2.2.10 Mutagenesis of Y. pseudotuberculosis 
Mutagenesis of Y. pseudotuberculosis was achieved by homologous recombination. 
Suicide plasmids were transferred into Yersinia via conjugation-competent E. coli 
S17-1λpir strains. For this purpose, Y. pseudotuberculosis cells and E. coli S17-1λpir 
cells carrying the plasmid of interest were grown overnight at 25°C and 37°C, 
respectively. 300 µl of E. coli cells were centrifuged (3 min, 2.755 g, room 
temperature) and washed twice with LB medium to remove traces of antibiotics. 
Subsequently, 900 µl of Y. pseudotuberculosis cells were added and centrifuged 
(3 min, 2.755 g, room temperature). The cells were resuspended in LB medium and 
incubated on filter membranes for 6 h to 12 h at 25°C. Afterwards, the cells were 
removed from the filter by vortexing in 1x PBS, the cell suspension was washed once 
with 1x PBS and plated on Yersinia selective solid medium with the appropriate 
antibiotic. Only Y. pseudotuberculosis cells with the integrated plasmid were able to 
grow on the selective medium. After a 2 days incubation at 25°C the bacteria were 
transferred to LB agar supplemented with 10% sucrose. The sacB gene encoded on 
the integrated suicide plasmid inhibits growth on sucrose, therefore only bacteria 
without the plasmid could grow on these plates. Fast growing colonies were analyzed 
for correct insertion of cloned DNA fragment by PCR and sequencing with primers 
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135/151. The Y. pseudotuberculosis strains YP268, YP269, YP270, YP271, YP279, 
YP286, YP287 and YP288 were constructed with Y. pseudotuberculosis strain 
YP107 and the plasmids pFS1, pFS8, pFS16, pFS17, pFS25, pFS26, pFS28 and 
pFS27, respectively.  
 
2.2.3 General molecular biological methods for RNA 
2.2.3.1  RNA isolation with hot phenol 
Isolation of total RNA was performed via the hot phenol method. For this purpose, 
50 ml of exponentially grown cultures at 25°C or 37°C were harvested by 
centrifugation (5 min, 10.000 g, 25°C or 37°C). The pellets were snap-frozen in liquid 
nitrogen and then resuspended in 250 µl RNA-resuspension buffer on ice. The 
resuspended cells were transferred to a 2 ml tube, mixed with lysis buffer and 
incubated at 65°C for 90 s. 500 µl of 65°C phenol-water were added to the lysed 
cells, intensively shaked and incubated at 65°C for 3 min. The suspension was 
frozen in liquid nitrogen for at least 30 s, centrifuged (10 min, 10.000 g, room 
temperature) and the aqueous phase was transferred to a new tube. This process 
was performed two more times. Then 300 µl of chloroform:isoamylalcohol (24:1) 
were added to the aqueous phase, mixed vigorously by vortexing and centrifuged 
(3 min, 10.000 g, room temperature). This step was repeated one more time. To 
precipitate the RNA, 1/10 volume of 3 M NaOAc pH 4.5 and 2.5 volume of 95% 
ethanol were added, mixed and incubated for at least 1 h at -20°C. The RNA was 
recovered by centrifugation (30 min, 10.000 g, 4°C). The pellet was washed once 
with ice-cold 70% ethanol (10 min, 10.000 g, 4°C), dried and resuspended in distilled 
water. The concentration of the RNA was measured with a NanoDrop 
spectrophotometer (PeqLab) at 260 nm.  
 
2.2.3.2  Northern blotting 
For Northern blotting 5 µg of total RNA were mixed with loading dye (0.03% 
bromophenol blue, 4 mM EDTA, 0.1 mg/ml EtBr, 2.7% formaldehyde, 31% 
formamide, 20% glycerol in 4x MOPS buffer), heated for 10 min at 70°C and loaded 
onto a 1.2% MOPS agarose gel. Gelelectrophoresis was performed for 100 min at 
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120 V in 1x MOPS buffer and an image was taken via a gel documentation system 
(Biorad) under UV-light to visualize the 23S and 16S rRNAs as loading control. The 
RNA was transferred on a positively charged membrane (GE Healthcare) by vacuum 
blotting for 1.5 h at 5 bar in 10x SSC buffer. 
Detection of the two CsrC transcripts was performed using a high-resolution urea-
acrylamide gel (4.2 g urea, 0.6 ml 10x TBE pH 8.0, 3 ml 40% acrylamide, 3.25 ml 
distilled water, 6 µl TEMED, 60 µl 10% APS). 10 µg of total RNA were mixed with 
loading dye (0.03% bromophenol blue, 0.5 mM EDTA, 20% SDS, 9.5 ml formamide) 
and heated for 10 min. The RNA was transferred on positively charged membranes 
(GE Healthcare) by semi-dry blotting for 30 min at 20 V in 0.5% TBE. 
The membrane was UV cross-linked twice in a UV cross-linker (Stratagene) at 
120.000 microjoules. For detection of the specific RNAs CsrB and CsrC DIG-labeled 
PCR fragments were amplified with primers 555/556 and 582/583, respectively, using 
DIG-PCR nucleotide mix (Roche). Prehybridization (1-2 hours, 42°C), hybridization 
(overnight, 42°C), washing and immunological detection were done using the DIG 
Luminescent Detection Kit (Roche) according to the manufacturer's advices.  
 
2.2.3.3  RNA stability assay 
To determine the stability of the small regulatory RNA CsrC transcription was 
inhibited with 2 mg/ml rifampicin. At given time points samples were taken, 0.2 
volumes of stop solution (5% water-saturated phenol, 95% ethanol) were added to 
the samples and snap-frozen in liquid nitrogen. After thawing on ice, the samples 
were centrifuged (10 min, 10.000 g, 4°C) and the RNA was isolated with the SV total 
RNA Purification Kit (Promega) according to the manufacturer's advices. The 
concentration of the RNA was determined in a NanoDrop spectrophotometer 
(PeqLab) at 260 nm. Separation of the RNA with agarose gels and detection with 
Northern blotting was performed as described in 2.2.3.2. 
To measure the half-life of CsrC, the amount of CsrC was determined 
densitometrically using the software ImageJ, normalized to the 23S and 16S rRNAs 
and plotted in half-logarithmic scale against time. With the help of an exponential 
regression curve the half-life was calculated. 
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2.2.4 Biochemical methods 
2.2.4.1  Expression and purification of recombinant PhoP protein  
E. coli BL21λDE3 pFS13 cells were grown at 37°C for 2-3 h and expression of His6-
PhoP was induced by addition of 1 mM IPTG (isopropyl-β-D-thiogalactoside). The 
cells were shifted to 18°C and harvested after 3-5 h by centrifugation (20 min, 6.000- 
9.000 g, 4°C). After one washing step with lysis buffer the pellet was resuspended in 
0.1 volumes of lysis buffer and cells were lysed in a French Press (Heinemann). The 
soluble His6-PhoP protein was purified using a Ni-NTA agarose column (Machery 
Nagel). For this purpose, the column was loaded twice with the lysate, washed with 
four column volumes of washing buffer and eluted with 2 ml elution buffer. The purity 
of His6-PhoP was verified by SDS-PAGE and staining of the gel with coomassie. The 
concentration of purified His6-PhoP was determined by Bradford assay, using the 
Coomassie Reagent Protein Assay Kit (Pierce) according to the manufacturer's 
advices. 250 µl of the Coomassie reagent were mixed with undiluted, a 1:10 and a 
1:100 protein dilution and incubated in a micro titer plate for 10 min at room 
temperature. The absorption was measured with an ELISA plate reader (BioRad) at 
595 nm and the concentration was determined via a BSA standard curve .  
 
2.2.4.2  SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE (Laemmli, 1970) is a technique for separation of proteins under 
denaturating conditions according to their molecular weight in an electric field. For 
sample preparation cells were centrifuged (60 sec, 14.000 g, room temperature), the 
pellet was resuspended in SDS sample buffer and heated for 10 min at 95°C. For an 
OD600 nm of 1 a volume of 100 µl sample buffer was used to lyse a bacterial pellet 
obtained from 1 ml culture. The gel is composed of a separating and a stacking gel 
with a different pH and polyacrylamide concentrations (Table 2.8). For smaller 
proteins (up to 25 kDa) a separating gel of 15% was prepared, while separating gels 
of 10% to 12% were used for bigger proteins (above 25 kDa). Electrophoresis was 
performed in a BioRad electrophoresis chamber at 25 mA per gel for 30 to 45 min in 
SDS running buffer. As size standard the PageRuler Prestained Protein Ladder 
(Thermo Scientific) was used (Fig. 2.2). 
 
Materials and methods  42 
 
Table 2.8 Composition of SDS gels  
Buffer/Solution stacking gel separating 
gel 10% 
separating 
gel 12% 
separating gel 
15% 
Separating gel 
buffer pH 8.8 
- 2.5 ml 2.5 ml 2.5 ml 
Stacking gel 
buffer pH 6.8 
1.25 ml - - - 
A. dest 3.25 ml 4.2 ml 3.5 ml 2.5 ml 
Acrylamide 
(30%) 
550 µl 3.3 ml 4 ml 5.0 ml 
TEMED 12.5 µl 25 µl 25 µl 25 µl 
APS (10%) 50 µl 100 µl 100 µl 100 µl 
 
After electrophoresis the gel was used for Western blotting or directly stained with 
coomassie staining solution for one to two hours and subsequently destained with 
water by heating. 
 
 
Fig. 2.2 PageRuler Prestained Protein Ladder (Thermo Scientific). 
 
2.2.4.3  Western blotting 
For Western blotting proteins were separated by SDS-PAGE and transferred 
electrophoretically on an Immobilon PVDF membrane (Millipore) for 60 min at 100 V 
in precooled transblot buffer in a blotting chamber (BioRad). To avoid unspecific 
binding of proteins the membrane was blocked afterwards for at least 1 hour in 
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blocking buffer (TBST buffer with either 3% BSA or 5% dried milk powder depending 
on the requirements of the primary antibody). Thereafter, the membrane was 
incubated with the primary antibody in blocking buffer under agitation for 1 hour at 
room temperature or overnight at 4°C. The membrane was washed 3 times for 5 min 
with TBST buffer and then incubated with the secondary antibody conjugated to 
horse radish peroxidase (HRP) for 1 hour at room temperature under agitation. After 
washing the membrane 3 times for 5 min with TBST buffer the blot was developed 
with the Western Lightning ECL II Kit (Perkin Elmer). 
 
2.2.4.4  β-galactodsidase activity assay 
Quantitative expression analyses were performed indirectly via the lacZ reporter 
system. The activity of the β-galactosidase enzyme encoded on a lacZ-fusion of 
choice was analyzed according to Miller (Miller, 1992). For this purpose, the promoter 
region of a gene of interest was fused to lacZ and expression quantified through β-
galactosidase activity. This enzyme catalyzes the cleavage of colourless ortho-
nitrophenyl-β-galactoside (ONPG), which results in the formation of yellow 
nitrophenol that can be measured photometrically. The amount of nitrophenol 
correlates directly with the β-galactosidase activity, which in turn depends on the 
strength of the expression. 
The OD600 nm of an exponential grown culture was measured and 200 µl of cells were 
lysed with one drop of 0.1% SDS and two drops of chloroform. After 5 min of 
incubation, 1.5 ml of Z-buffer were added. The reaction was started by the addition of 
400 µl ONPG (4 mg/ml) and stopped with 1 ml Na2CO3 after a certain time period. 
The absorption of the sample was determined in a micro titer plate with an ELISA 
reader (BioRad) at 420 nm. The specific enzyme activity was calculated as follows: 
OD420 nm * 6.648-1 * OD600 nm * t [min]-1 * V [ml]. 
 
OD420 nm: optical density of stopped reaction 
6.648: extinction coefficient of cleaved ONPG 
OD600 nm: optical density of bacterial culture 
V: culture volume 
t: time from start to stop of enzyme reaction 
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2.2.4.5  Electrophoretic mobility shift assay (EMSA) 
For DNA-binding studies of PhoP with the csrC upstream region recombinant His6-
PhoP protein was dialysed against binding buffer. Three different fragments of the 
csrC upstream region were amplified by PCR from genomic DNA of 
Y. pseudotuberculosis YPIII. One fragment containing two putative binding sites of 
PhoP was amplified with primers IV937/IV939, while the other two fragments 
harboring either binding site one or two were amplified with primers IV938/IV939 and 
IV937/IV940, respectively. As negative control part of the gyrA gene was amplified 
with primer pair III186/III187. For the binding reaction, 200 fmol of each DNA 
fragment were used and incubated with increasing amounts of PhoP in binding buffer 
in a 20 µl reaction mixture for 20 min at 25°C. After incubation, the reaction mixture 
was loaded onto a 5% polyacrylamide gel, gel electrophoresis was performed at 70 V 
and subsequently the gel was stained with ethidium bromide. To measure the 
dissociation constant Kd of each fragment, the relative amount of unbound DNA was 
determined densitometrically using the software ImageJ and plotted against 
increasing amounts of PhoP. The Kd was calculated with the help of a regression 
curve of three independent experiments.  
 
2.2.4.6  DNase I footprinting 
To determine the precise binding region of PhoP within the promoter region of csrC a 
DNase I footprint assay was performed. For this purpose, the csrC upstream region 
was amplified from Y. pseudotuberculosis YPIII with either a sense (I293) or an anti-
sense (V586) digoxigenin (DIG)-labeled primer and the unlabeled primer I79 or V587, 
respectively. The purified His6-PhoP protein was either preincubated with 20 mM 
acetyl phosphate for 30 min at 25°C for phosphorylation or directly used for the 
footprinting reaction. The purified DIG-labeled DNA fragment was incubated with 
increasing concentrations of the His6-PhoP protein for 20 min at 25°C in binding 
buffer as described for the EMSA. The reaction mixture was digested with a suitable 
dilution of DNase I for exactly 20 s and stopped by the addition of 50 µl stop solution 
(15 mM EDTA, 10 µg ml-1 yeast carrier tRNA). To extract the DNA, phenol-
chloroform-isoamylalcohol (25:24:1) was added and the DNA was precipitated with 
ethanol. After washing with 70% ethanol, the pellet was dried and then resuspended 
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in 5 µl sequencing blue marker (Sequenase sequencing kit). The samples were 
loaded on a 6% polyacrylamide sequencing gel, run for 3 h at 60 W and afterwards 
transferred to a Nytran N membrane (GE Healthcare) by capillary blotting. After UV 
cross-linking, the DNase I footprint reaction was developed using CDP-star of the 
DIG Luminescent Detection kit (Roche) according to the manufacture’s advices.  
 
2.2.5 Mouse experiments 
Mouse experiments were performed according to the standard recommendations of 
FELASA (Federation of Laboratory Animal Science Associations) and handled with 
appropriate care and welfare. Mice were housed in the animal facility at the 
Helmholtz Centre for Infection Research, Braunschweig, under specific pathogen-
free conditions according to GV-SOLAS (German Recommendations of the Society 
for Laboratory Animal Science). For all mouse experiments, 6-8 weeks old female 
BALB/c mice were purchased from Janvier (Saint Berthevin Cedex, France). 
 
2.2.5.1 Oral infection 
Infection of mice with Y. pseudotuberculosis was performed orally with a buttoned 
cannula to mimic the natural infection route. Prior to infection, mice were starved 
overnight. The bacteria were grown at 25°C in 25 ml LB liquid media overnight and 
harvested by centrifugation (10 min, 2.775 g, 25°C). The pellet was washed twice 
with sterile PBS, resuspended in PBS and the OD600 nm was measured and adjusted. 
200 µl of the bacterial suspension were used for the infection of each mouse. 
Determination of the infection dose was achieved by plating different dilutions of the 
bacterial suspension on LB agar. 
 
2.2.5.2  Survival experiments 
The virulence of the bacteria was determined by survival experiments. Therefore 
mice were infected orally with 2*108 CFU of different Y. pseudotuberculosis strains 
as described in 2.2.5.1 and health status as well as body weight were monitored for 
at least 14 days. The mice were sacrificed when the body weight was below 80% in 
comparison to the weight before infection. 
Materials and methods  46 
 
2.2.5.3  Organ burden experiments 
To determine the bacterial load in specific organs of mice, organ burden experiments 
were performed. Therefore, mice were orally infected as described in 2.2.5.1 with 
2*108 CFU of different Y. pseudotuberculosis strains. One, three and five days after 
infection, mice were euthanized by CO2 asphyxiation and Peyer's patches (PP), 
mesenteric lymph nodes (MLN), spleen, liver and caecum were dissected. The 
organs were weighted and homogenized in sterile PBS with the Polytron PT 2100 
homogenizer (Kinematica, Switzerland) at 30.000 rpm for 30 s. Different dilutions 
were plated on LB agar plates and the CFU was calculated per g organ/tissue. 
 
2.2.5.4 Cryosections 
Cryosections of different organs were performed to determine the localization of 
bacteria expressing rovA. Therefore BALB/c mice were orally infected as described 
in 2.2.5.1 with 2*108 CFU of Y. pseudotuberculosis harboring plasmid pFS48 (Ptet-
mCherry) and plasmid pKH70 (ProvA-egfpLVA). Three days post infection mice were 
euthanized by CO2 asphyxiation and PP and caecum were isolated. The organs were 
frozen on dry ice in Tissue-Tek OCT freezing medium (Sakura Finetek). Cryosections 
of 6-8 µm were prepared with a Microm HM 560 cryostat (Thermo Scientific), 
mounted on SuperFrost Plus slides (Thermo Scientific) and fixed for 20 min with ice-
cold 4% PFA. The fixed slides were washed twice with 1x PBS and air-dried. For cell-
nuclei staining and mounting of samples Roti-Mount FluorCare (Roth) was used. 
Samples were imaged using the Axiovert II fluorescence microscope (Zeiss) with an 
Axiocam HR digital charge-coupled device (CCD) camera (Zeiss) and the software 
ZEN 2012 (Zeiss). 
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3 Results 
The enteropathogenic bacterium Y. pseudotuberculosis enters the host via M-cells in 
the epithelial layer of the gut. For the invasion and colonization of the host several 
early-phase virulence factors like the invasin InvA are necessary (Marra and Isberg, 
1997). The expression of invA is especially important for the start of infection, as InvA 
mediates the interaction with M-cells, while it is not required for the later-phase of 
infection (Clark et al., 1998; Isberg and Leong, 1990). Moreover, InvA is highly 
immunogenic and therefore a disadvantage for the bacteria after entering the host 
(Gillenius and Urban, 2015; Grassl et al., 2003a). Thus, constitutive expression of 
virulence factors is not profitable with respect to immune evasion and also energy 
consumptive.  Hence, the expression of virulence factors has to be tightly controlled 
in order to ensure a successful infection. RovA, the regulator of virulence A, is one 
major regulator of early-phase virulence factors like InvA (Nagel et al., 2001). RovA 
acts as thermosensor by altering its conformation during a temperature shift from 
25°C to 37°C and is thereby able to distinguish between environment and host 
(Herbst et al., 2009). In a mathematical model the expression of rovA was predicted 
to be bistable in a temperature-dependent manner (Müller J.; Münch R., unpublished 
data). Requirements for the bistable expression of a protein are positive or double 
negative feedback loops within the regulatory network of a transcriptional regulator in 
combination with a non-linear response, such as cooperative DNA-binding or 
regulated proteolysis (Ferrell, 2002; Smits et al., 2006). In first experiments the 
temperature-dependent bistable expression of rovA could be confirmed 
(Herbst, K., PhD thesis; Nuss, A. M., unpublished data).  
The present study investigates the underlying molecular mechanisms leading to 
bistable rovA expression as well as their role for virulence of Y. pseudotuberculosis. 
 
3.1 Temperature-dependent bistable expression of rovA 
Monitoring heterogeneous gene expression involves the analysis on single cell level, 
usually via a suitable reporter gene. For the analysis of bistable rovA expression the 
reporter gene egfpLVA was used. Since eGFP is a very stable protein with a half-life of 
approximately 24 hours, rapid changes in gene expression cannot be detected. To 
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overcome this problem, a LVA-tag for faster protein degradation was attached 
(Andersen et al., 1998; Herbst, K., PhD thesis). LVA is a variant of SsrA-tags and 
mainly degraded by Clp-proteases. eGFP carrying the LVA-tag has a decreased half-
life of about 40 min, which is more useful for studying dynamics of gene expression 
(Andersen et al., 1998).  
 
3.1.1 Validation of bistable rovA expression  
To confirm bistable rovA expression plasmid pKH70 carrying a ProvA-egfpLVA fusion 
was transformed into competent Y. pseudotuberculosis YPIII cells, which were grown 
to exponential growth phase at different temperatures and analyzed for ProvA-egfpLVA 
expression by fluorescence microscopy (Fig. 3.1). Microscopic pictures show a 
homogenous expression of the reporter fusion at 25°C and 37°C, in which all cells 
are eGFP-positive or eGFP-negative, respectively (Fig. 3.1 A). However, at 32°C 
ProvA-egfpLVA is heterogeneously expressed. Two cell types were detectable, one with 
green fluorescence due to RovA-dependent egfpLVA expression (“ON”) and a second 
one, in which rovA is not expressed without any green fluorescence (“OFF”). To 
examine the temperature range in which bistable expression of ProvA-egfpLVA can be 
observed, bacteria were grown at 25°C and between 30°C to 37°C and ProvA-egfpLVA 
expression was analyzed by flow cytometry (Fig. 3.1 B, D). At intermediate 
temperatures (30°C to 34°C) two distinct subpopulations with either high (“ON”) or 
low/no ProvA-egfpLVA expression (“OFF”) could be detected. With increasing 
temperatures, the amount of eGFP-positive cells gradually decreases. The gating 
strategy for eGFP-positive and eGFP-negative bacteria of an in vitro culture is shown 
in Fig. S1. Furthermore, the amount of RovA expressed from the chromosomal copy 
was determined (Fig. 3.1 C). The RovA-levels analyzed by Western blot reflect the 
eGFP-levels of the flow cytometry analysis: with increasing temperatures a lower 
amount of RovA was observed. 
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Fig. 3.1 Expression of a ProvA-egfpLVA reporter fusion at various temperatures.  
Y. pseudotuberculosis YPIII cells harboring plasmid pKH70 (ProvA-egfpLVA) were grown to exponential 
growth phase and samples were taken at different temperatures for microscope, flow cytometry and 
Western blot analysis. (A) Microscopic pictures at 25°C, 32°C and 37°C. (B) Quantification of eGFP-
positive and eGFP-negative cells at indicated temperatures measured by flow cytometry. The data 
show the mean ± SEM of three independent experiments performed in triplicates. (C) Whole cell 
extracts were prepared, separated on 15% SDS-polyacrylamide gels and RovA expressed from the 
chromosomal rovA gene was analyzed by blotting using a specific RovA antibody, (c – loading 
control). (D) Intensity of eGFP fluorescence at different temperatures is shown in a histogram.  
 
To proof that bistable rovA expression is not based on a temperature-dependent 
eGFPLVA synthesis or proteolysis, egfpLVA was expressed under the control of the 
constitutive rho promoter in plasmid pFS5 and its expression was tested at different 
temperatures by flow cytometry (Fig. 3.2). At the investigated temperatures all cells 
express eGFPLVA with a high intensity. This demonstrates that bistable rovA 
expression is specific and not a result of a temperature-dependent expression or 
degradation of eGFPLVA.  
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Fig. 3.2 Expression of a Prho-egfpLVA reporter fusion at various temperatures.  
Y. pseudotuberculosis YPIII cells harboring plasmid pFS5 (Prho-egfpLVA) were grown to exponential 
growth phase and samples were taken at different temperatures for flow cytometry. (A) Quantification 
of eGFP-positive and eGFP-negative cells at indicated temperatures measured by flow cytometry. The 
data show the mean ± SEM of two independent experiments performed in duplicates or triplicates. (B) 
Intensity of eGFP fluorescence within the bacterial population at different temperatures is shown in a 
histogram.  
 
3.1.2 Time-lapse microscopy reveals reversibility and hysteresis  
In order to follow RovA-dependent expression of egfpLVA on single cell level over 
several generations time-lapse microscopy was performed. For this purpose, bacteria 
were grown to exponential growth phase at 32°C and observed using time-lapse 
microscopy for several hours (Fig. 3.3). The data show heterogeneous expression of 
ProvA-egfpLVA in a growing microcolony. Observing cells starting in the “ON” state 
(ProvA-egfpLVA expression) shows that these cells tend to stay in the “ON” state 
(Fig. 3.3 A). Vice versa a microcolony that starts from an “OFF” cell (no ProvA-egfpLVA 
expression) remains preferably in this state (Fig. 3.3 B). Nevertheless, spontaneous 
switching from one state to the other can be observed and shows reversibility and 
hysteresis, a characteristic of bistable systems. Hysteresis describes a memory-like 
behavior of cells in which they tend to stay in the state of their ancestors (Ninfa and 
Mayo, 2004; Veening et al., 2008a).  
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Fig. 3.3 Time-lapse microscopy of Y. pseudotuberculosis at 32°C.  
Y. pseudotuberculosis YPIII cells harboring plasmid pKH70 (ProvA-egfpLVA) were grown for two hours at 
32°C, diluted 1:10 in LB media and incubated in a micro-dish under the microscope at 32°C. Growth of 
cells was monitored using the Axiovert II fluorescence microscope (Zeiss) and images were taken 
every 15 min. Analysis started either from eGFP-positive cells (A) or eGFP-negative cells (B). White 
bars indicate 10 µm. 
 
3.1.3 Bistable rovA expression is affected by thermosensing and proteolysis 
To gain information about the molecular mechanisms underlying bistable rovA 
expression, mutants altered in stability and thermosensing of RovA were constructed 
and analyzed. Previous investigations revealed that RovA stability is enhanced at 
37°C in Y. enterocolitica O:3 (Uliczka et al., 2011). A substitution of proline to serine 
at position 98 is responsible for the increased stability, but does not affect 
thermosensing of RovA (Uliczka et al., 2011). An exchange of P98S in 
Y. pseudotuberculosis YPIII also affects stability of RovA and leads to increased 
stability at 37°C (Mendonca, C., PhD thesis). Moreover, a comparison of RovA of 
Y. pseudotuberculosis and SlyA of Salmonella enterica serovar Typhimurium 
revealed differences in stability and DNA-binding affinity at 37°C. Amino acid G116 
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was identified to be responsible for the thermosensing capacity of RovA, while amino 
acids SG127/128 renders the protein more susceptible to degradation (Quade et al., 
2012). As a consequence, an exchange of G116A leads to an increased DNA-
binding affinity at 37°C. Additionally, substitution of amino acids SG127/128IK 
increases stability of RovA (Quade et al., 2012).  
Based on these findings, gene variants of rovA were constructed within the original 
rovA locus on the chromosome leading to RovA mutations with amino acid 
substitutions of P98S, G116A and SG127/128IK. Y. pseudotuberculosis wild type 
strain and the different rovA mutants carrying plasmid pKH70 (ProvA-egfpLVA) were 
grown to exponential growth phase at temperatures ranging from 25°C to 37°C and 
rovA expression was analyzed by flow cytometry and Western blot (Fig. 3.4). As 
previously described, bistable expression of ProvA-egfpLVA was observed at growth 
temperatures between 30°C and 34°C in the wild type strain (Fig. 3.4 A). About 50% 
of cells were in the “ON” and 50% in the “OFF” state was observed at 32°C. Loss of 
the thermosensing activity of RovA due to the G116A substitution affects the pattern 
of bistable ProvA-egfpLVA expression (Fig. 3.4 B). The temperature range, in which 
bistable expression occurs, appears to be broader in comparison to the wild type, two 
subpopulations can be observed between 31°C and 36°C. Exchange of the amino 
acids SG127/128IK had a similar effect on the distribution of bistable expression, but 
in contrast to YP270 (RovAG116A) less eGFP-positive cells could be observed at 36°C 
(Fig. 3.4 C). The lowest impact on bistable ProvA-egfpLVA expression was visible for 
YP269 (RovAP98S) (Fig. 3.4 D). The results were verified by Western blotting. A 
gradual temperature up-shift leads to a decrease of the RovA-level within the entire 
population, which equals the percentage of eGFP-positive cells at the respective 
temperature.  
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Fig. 3.4 Analysis of bistable rovA expression in YPIII expressing different RovA variants.  
Y. pseudotuberculosis YPIII wild type strain as well as mutants expressing a stabilized version of 
RovA harboring the plasmid pKH70 (ProvA-egfpLVA) were grown to exponential growth phase and 
samples were taken at indicated temperatures for flow cytometry and Western blot analysis. Upper 
panels show quantification of eGFP-positive and eGFP-negative cells measured by flow cytometry. 
The data show the mean ± SEM of three independent experiments performed in triplicates. Lower 
panels show Western blots of chromosomally encoded RovA using a RovA specific antibody (c – 
loading control). (A) YPIII wild type RovA (wt), (B) YP270 (RovAG116A), (C) YP271 (RovASG127/128IK), (D) 
YP269 (RovAP98S).  
 
The stabilized variants RovAP98S, RovAG116A and RovASG217/128IK led to a modulation 
of bistable ProvA-egfpLVA expression pattern and to expression of rovA at higher 
temperatures, but not at host body temperature (37°C). In order to further shift rovA 
expression to higher temperatures and to abolish RovA bistability entirely, multiple 
substitutions were integrated into the RovA protein to further increase stability and 
DNA binding affinity. The generated mutants were analyzed by flow cytometry and 
Western blotting (Fig. 3.5). The bistable expression of ProvA-egfpLVA is still present, 
but shifted to higher temperatures. Only a very low ProvA-egfpLVA expression could be 
observed in strain YP279 (RovAP98S, SG127/128IK) at 37°C, in which degradation but not 
thermosensing is affected (Fig. 3.5 A). Loss of the thermosensing capacity in 
0
50
100 GFP+
GFP-
%
 c
el
ls
T [°C]
RovA
c
25 30 31 32 33 34 35 36 37°C
A B
25 30 31 32 33 34 35 36 37
GFP+
GFP-
T [°C]
25 30 31 32 33 34 35 36 37
0
50
100
%
 ce
lls
YP270 (RovAG116A)YPIII (wt)
GFP+
GFP-
T [°C]
25 30 31 32 33 34 35 36 37
0
50
100
%
 c
el
ls
YP269 (RovAP98S)C
GFP+
GFP-
T [°C]
25 30 31 32 33 34 35 36 37
0
50
100
%
 c
el
ls
DYP271 (RovASG127/128IK)
RovA
c
25 30 31 32 33 34 35 36 37°C
RovA
c
25 30 31 32 33 34 35 36 37°C
RovA
c
25 30 31 32 33 34 35 36 37°C
Results  54 
 
connection with decreased proteolysis, either through substitution of G116A 
and SG127/128IK or G116A and P98S leads to expression of ProvA-egfpLVA in about 
20% to 25% of the bacteria at 37°C (Fig. 3.5 B, C). In order to further increase the 
ratio of cells in the “ON” state at 37°C, a stabilized RovA variant with multiple 
substitutions was constructed and tested on bistable of ProvA-egfpLVA expression 
(Fig. 3.5 D). However, only a slight increase of cells in the “ON” state could be 
observed at 37°C in strain YP287 expressing the stabilized RovAG116A, P98S, SG127/128IK 
variant.  
 
 
Fig. 3.5 Effect of multiple amino acid substitutions within the RovA protein on bistable rovA 
expression.  
Mutants expressing different stabilized versions of RovA harboring the plasmid pKH70 (ProvA-egfpLVA) 
were grown to exponential growth phase and samples were taken at indicated temperatures for flow 
cytometry and Western blot analysis. Upper panels show quantification of eGFP-positive and eGFP-
negative cells measured by flow cytometry. The data show the mean ± SEM of three independent 
experiments performed in triplicates. Lower panles show Western blots of chromosomally encoded 
RovA using a RovA specific antibody (c – loading control). (A) YP279 (RovAP98S, SG127/128IK), (B) YP286 
(RovAG116A, SG127/128IK) (C) YP288 (RovAG116A, P98S), (D) YP287 (RovAG116A, P98S, SG127/128IK).  
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Taken together, the thermosensing capacity as well as the temperature-dependent 
proteolysis of RovA strongly affect bistable expression of rovA. Nevertheless, 
uncoupling of these factors does not lead to an abrogation of bistability.  
 
3.1.4 rovA is bistably expressed under the control of a constitutive promoter 
and in a ΔrovM mutant 
As mentioned before, a positive or double negative feedback loop combined with a 
non-linear response, such as regulated proteolysis, is required for the formation of 
bistability (Ferrell, 2002; Smits et al., 2006). Diminished degradation and enhanced 
DNA-binding affinity of RovA led to a shift of bistable rovA expression to higher 
temperatures, but did not abolish RovA bistability (see Fig. 3.4, 3.5).  
To test the impact of the positive and negative feedback loop on bistable rovA 
expression when a stabilized variant of RovA is expressed, rovAP98S, G116A, SG127/128IK 
was expressed under the control of a constitutive promoter. Therefore, plasmids 
pFS46 (Ptet-rovAP98S, G116A, SG127/128IK) and pKH70 (ProvA-egfpLVA) were transformed 
into Y. pseudotuberculosis YP107 (ΔrovA). The rovA deletion mutant was used to 
exclude any effects of chromosomally encoded wild type RovA. Bacteria were grown 
to exponential growth phase at different temperatures and samples were taken for 
flow cytometry and Western blotting (Fig. 3.6). At temperatures up to 33°C almost all 
cells express egfpLVA in a RovA-dependent manner and at 35°C and 36°C 
approximately 75% of the population are eGFP-positive. However, at 37°C only 
about 20% of all cells are eGFP-positive, showing that even if a stabilized RovA is 
expressed under the control of a constitutive promoter, bistable rovA expression 
cannot be abolished at 37°C. 
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Fig. 3.6 rovA expression under control of the constitutive tet-promoter.  
Y. pseudotuberculosis YP107 (ΔrovA) harboring plasmids pFS46 (Ptet-rovAP98S, G116A, SG127/128IK) and 
pKH70 (ProvA-egfpLVA) was grown to exponential growth phase and samples were taken at indicated 
temperatures for flow cytometry and Western blot analysis. Upper panel shows quantification of 
eGFP-positive and eGFP-negative cells measured by flow cytometry. The data show the mean ± SEM 
of three independent experiments performed in triplicates. Lower panel shows a Western blot of 
chromosomally encoded RovA using a RovA specific antibody (c – loading control).  
 
Besides the autoregulatory loop, the proteolysis and thermosensing domains of 
RovA, another regulatory component of the network controlling RovA synthesis was 
identified to affect heterogeneous expression of rovA. The transcriptional regulator 
RovM binds directly to the promoter region of rovA and represses rovA transcription 
(Heroven and Dersch, 2006). By using plasmid pKH70 a shift of bistable ProvA-egfpLVA 
expression to higher temperatures could be determined in a ΔrovM mutant (Fig. 3.7). 
While the entire population express ProvA-egfpLVA up to temperatures of 33°C, 
bistable expression was observed from 34°C to 36°C.  
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Fig. 3.7 Bistable expression of ProvA-egfpLVA in a ΔrovM mutant.  
Y. pseudotuberculosis YP72 (ΔrovM) harboring plasmid pKH70 (ProvA-egfpLVA) was grown to 
exponential growth phase and samples were taken at indicated temperatures for flow cytometry and 
Western blot analysis. Upper panel shows quantification of eGFP-positive and eGFP-negative cells 
measured by flow cytometry. The data show the mean ± SEM of three independet experiments 
performed in triplicates. Lower panel shows a Western blot of chromosomally encoded RovA using a 
RovA specific antibody (c – loading control; experiment was performed in cooperation with Nuss, 
A. M).  
 
Based on these results and in order to increase the percentage of eGFP-positive 
cells at 37°C, rovAP98S, G116A, SG127/128IK was expressed under the control of a 
constitutive promoter in a ΔrovM mutant strain. Therefore, plasmid pFS46 (Ptet-
rovAP98S, G116A, SG127/128IK) and plasmid pKH70 (ProvA-egfpLVA) were transformed in 
strain YP72 (ΔrovM) and analyzed by flow cytometry and Western blot (Fig. 3.8). 
Only a slight increase of eGFP-positive cells could be detected at 35°C and 36°C in 
comparison to the ProvA-egfpLVA expression in ∆rovA mutant, while the percentage of 
eGFP-positive cells is similar comparing the rovA deletion mutant with the rovM 
deletion mutant at 37°C (see Fig. 3.6).  
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Fig. 3.8 RovA-dependent egfpLVA expression in a ΔrovM mutant under control of the 
constitutive tet-promoter.  
Y. pseudotuberculosis YP72 (ΔrovM) harboring plasmids pFS46 (Ptet-rovAP98S, G116A, SG127/128IK) and 
pKH70 (ProvA-egfpLVA) was grown to exponential growth phase and samples were taken at indicated 
temperatures for flow cytometry and Western blot analysis. Upper panel shows quantification of 
eGFP-positive and eGFP-negative cells measured by flow cytometry. The data show the mean ± SEM 
of three independent experiments performed in triplicates. Lower panel shows a Western blot of 
chromosomally encoded RovA using a RovA specific antibody (c – loading control).  
 
In summary, the previous results show that bistability of RovA is very robust to 
perturbations and could not be abolished by mutations that stabilize RovA even if this 
RovA version is expressed constitutively in a rovM deletion mutant. 
 
3.1.5 Stabilized RovA enhances invA expression at 37°C 
Invasin was shown to be a direct target of RovA in Y. pseudotuberculosis (Nagel et 
al., 2001). As a result of RovA-dependent regulation invA is expressed at 25°C, but 
not at 37°C (Nagel et al., 2001). Immunostainings of invasin of YPIII grown at 32°C 
revealed that RovA-positive cells carry more invasin on the cell surface than RovA-
negative cells (Fig. S2, Nuss, A. M.). 
Exchanges of the aminoacids P98S, G116A and SG127/128IK within the RovA 
protein result in expression of RovA at temperatures up to 37°C. To monitor if a 
stabilized RovA would also lead to expression of invA at host body temperatures 
(37°C), Western blotting of invasin was performed in Y. pseudotuberculosis YPIII 
(wt), YP269 (RovAP98S), YP270 (RovAG116A) and YP287 (RovAP98S, G116A, SG127/128IK) 
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(Fig. 3.9). Neither in the wild type strain nor in the stabilized mutants YP269 
(RovAP98S) and YP270 (RovAG116A) invasin was detectable at 37°C. Only in the most 
stabilized mutant YP287 (RovAP98S, G116A, SG127/128IK) invasin could be detected. The 
amount of invasin correlates with the RovA-level at 37°C in the respective mutants, 
which illustrates that invA expression correlates with the amount of RovA (see 
Fig. 3.4, 3.5). 
 
 
Fig. 3.9 invA expression at 37°C in RovA mutants expressing stabilized versions of RovA.  
Y. pseudotuberculosis YPIII (wt), YP269 (RovAP98S), YP270 (RovAG116A) YP287 (RovAP98S, G116A, 
SG127/128IK), YP107 (ΔrovA), and YP192 (ΔinvA) were grown to exponential growth phase at 37°C and 
samples were taken for Western blotting. Whole cell extracts were prepared, separated on 12% SDS-
polyacrylamide gels and chromosomally encoded InvA was analyzed with an InvA specific antibody (c 
– loading control). 
 
3.2 Strain-specific differences in the bistable expression of rovA 
To gain information whether bistable expression of rovA varies between different 
Y. pseudotuberculosis strains, bistable rovA expression was also investigated in the 
clinical isolate IP32953. Therefore, the bacteria carrying plasmid pKH70 (ProvA-
egfpLVA) were grown to exponential growth phase at different temperatures and 
analyzed by flow cytometry and Western blot (Fig. 3.10). Bistable expression of ProvA-
egfpLVA could be observed from 34°C to 36°C. The amount of RovA within the entire 
population correlates with the flow cytometry data and shows a decrease of RovA 
amounts with increasing temperatures. Comparing RovA-dependent expression of 
egfpLVA in Y. pseudotuberculosis strains YPIII and IP32953 reveals expression of 
RovA at higher temperatures in strain IP32953 (see Fig. 3.1 B). 
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Fig. 3.10 Bistable expression of ProvA-egfpLVA in Y. pseudotuberculosis IP32953.  
Y. pseudotuberculosis IP32953 harboring plasmid pKH70 (ProvA-egfpLVA) was grown to exponential 
growth phase and samples were taken at indicated temperatures for flow cytometry and Western blot 
analysis. Upper panel shows quantification of eGFP-positive and eGFP-negative cells measured by 
flow cytometry. The data show the mean ± SEM of three independent experiments performed in 
duplicates or triplicates. Lower panel shows Western blots of chromosomally encoded RovA using a 
RovA specific antibody (c – loading control).  
 
One main difference between the two isolates is the presence of a functional PhoP, 
which is the response regulator of the two-component system PhoP/PhoQ. While 
Y. pseudotuberculosis IP32953 encodes a functional PhoP, Y. pseudotuberculosis 
YPIII encodes only a truncated version of the phoP gene through a T160P amino 
acid substitution (Grabenstein et al., 2004). In Y. pestis it was described that PhoP 
directly controls expression of rovA by repression of rovA transcription (Zhang et al., 
2011). Expression of slyA, the rovA homologue of S. enterica serovar Typhimurium, 
was shown to be activated by PhoP (Norte et al., 2003). In order to examine the role 
of PhoP on rovA expression in Y. pseudotuberculosis and unravel a possible 
implication in bistability of RovA, the two clinical isolates YPIII and IP32953 of 
Y. pseudotuberculosis were used for this investigation. Furthermore, isogenic phoP 
mutants of the two strains were analyzed: YP149, which is the phoP-positive 
derivative of YPIII, and YPIP6, which is the phoP-negative derivative of IP32953. 
 
3.2.1 PhoP acts positively on rovA expression 
In order to gain information on rovA expression dependent on PhoP, the promoter 
activity of a translational rovA-lacZ fusion (pCM33) was determined in the 
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Y. pseudotuberculosis strains YPIII (phoP-) and IP32953 (phoP+) and their respective 
phoP-positive and phoP-negative derivatives. The β-galactosidase activity was 
measured in the different strains during exponential growth (Fig. 3.11 A). At 25°C the 
β-galactosidase activity in the phoP-positive derivatives is significantly higher than in 
the phoP-negative derivatives. In contrast, at 37°C a basal expression of rovA-lacZ 
was observed in all strains with only a slight difference between the phoP-positive 
and phoP-negative derivatives of IP32953 and YPIII. Western blots are consistent 
with these data and show a higher amount of RovA in the phoP-positive derivatives 
compared to phoP-negative derivatives at 25°C (Fig. 3.11 B). 
 
 
Fig. 3.11 PhoP regulates rovA expression positively in Y. pseudotuberculosis.  
Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivatives were grown to exponential growth phase at 25°C or 37°C as indicated. (A) The β-
galactosidase activity of a translational rovA-lacZ (pCM33) fusion was determined. The data represent 
the mean ± SEM of three independent experiments performed in triplicates. Data were analyzed by 
Student’s t-test (*, P<0.05; **, P <0.01; ***, P <0.001; n.s. – not significant). (B) Whole cell extracts 
were prepared, separated on 15% SDS-polyacrylamide gels and analyzed by Western blotting with a 
RovA specific antibody. YP107 (ΔrovA) was used as negative control (c – loading control). 
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3.2.1.1 PhoP-dependent activation of rovA expression is mediated by RovM 
Furthermore, it was analyzed whether PhoP controls rovA expression directly or 
indirectly. For this purpose, the regulatory network of RovA was examined. The 
LysR-type regulator RovM was shown to repress rovA expression directly by binding 
upstream of promoter P1 (Heroven and Dersch, 2006).  
To investigate whether synthesis of RovM is PhoP-dependent, the RovM protein 
level was examined in the different phoP-positive and phoP-negative derivatives of 
YPIII and IP32953. To do so, the different strains were grown to exponential growth 
phase and samples were taken at 25°C and 37°C and analyzed by Western blotting 
(Fig. 3.12). At both temperatures increased RovM-levels were observed in the phoP-
deficient strains in comparison to the phoP-positive strains. This indicates that the 
PhoP-mediated positive regulation of rovA is indirect and occurs via RovM. 
Additionally, RovM is more abundant in the IP32953 background, which leads to the 
assumption that other regulatory factors besides PhoP contribute to RovM regulation. 
 
 
Fig. 3.12 Impact of PhoP on rovA expression is mediated through RovM.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C or 37°C as indicated and 
samples were taken for Western blotting using a specific RovM antibody. YP72 (ΔrovM) served as 
negative control (c – loading control). 
 
3.2.1.2 Expression of crp and csrA is not affected by PhoP 
Besides temperature, expression of rovA depends on the nutrient availability of the 
surrounding media (Heroven et al., 2012a; Nagel et al., 2001). In minimal media rovA 
is repressed, which is mediated by Crp and the Csr-system via RovM (see Fig. 1.6) 
(Heroven and Dersch, 2006; Heroven et al., 2012a). Since PhoP-dependent 
activation of rovA occurs via RovM, it is possible that the Csr-system or Crp is 
involved in this regulation, which was further investigated. In addition, it was recently 
shown, that crp is directly activated by PhoP in Y. pestis (Zhang et al., 2013).  
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In order to test whether PhoP acts on crp, the respective phoP-positive and phoP-
negative derivatives of YPIII and IP32953 were grown to exponential growth phase at 
25°C and 37°C and the β-galactosidase activity of a translational crp-lacZ fusion was 
determined (Fig. 3.13 A). No significant differences in the β-galactosidase activity 
were observed neither at 25°C nor at 37°C. 
To confirm the reporter fusion experiment and exclude differences in the stability of 
Crp, Western blot analysis of Crp was performed (Fig. 3.13 B). Consistent with the 
data of the β-galactosidase assay, no differences between phoP-positive and phoP-
negative strains could be detected, indicating that PhoP has no impact on Crp 
expression in Y. pseudotuberculosis.  
 
 
Fig. 3.13 Crp is not involved in PhoP-dependent regulation of rovA.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C or 37°C as indicated. (A) The β-
galactosidase activity of a translational crp-lacZ (pAKH139) fusion was determined. The data 
represent the mean ± SEM of three independent experiments performed in triplicates. Data were 
analyzed by Student’s t-test and do not differ statistically significant (n.s. – not significant). (B) Whole 
cell extracts were prepared, separated on 15% SDS-polyacrylamide gels and analyzed by Western 
blotting with a Crp specific antibody. YP89 (Δcrp) was used as negative control (c – loading control). 
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Furthermore, it was tested whether PhoP has an effect on csrA expression. To do so, 
the β-galactosidase activity of a translational csrA-lacZ fusion was determined in 
bacteria grown to exponential growth phase (Fig. 3.14). At 25°C and 37°C no 
significant differences could be detected, indicating that PhoP has no influence on 
csrA expression. 
 
 
Fig. 3.14 Impact of PhoP on csrA expression in Y. pseudotuberculosis.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C or 37°C as indicated. The β-
galactosidase activity of a translational csrA-lacZ (pKB63) fusion was determined. The data represent 
the mean ± SEM of three independent experiments performed in triplicates. Data were analyzed by 
Student’s t-test (n.s. – not significant). 
 
3.2.1.3 CsrC is involved in PhoP-dependent activation of rovA expression 
An impact of PhoP on the Csr-system can still not be excluded, since the amount of 
free CsrA and activity of CsrA was not examined. CsrB and CsrC are small non-
coding RNAs, which sequester CsrA from target mRNAs and thereby inhibit the 
function of CsrA (Heroven et al., 2008; Romeo et al., 2013). Increasing amounts of 
CsrB or CsrC would lead to decreased levels of active CsrA in the cell, although the 
expression of csrA does not change. Therefore expression analyses of csrB and 
csrC were performed in the different phoP-positive and phoP-negative derivatives 
(Fig. 3.15, Fig. 3.16).  
Only low β-galactosidase activity of a csrB-lacZ fusion could be observed and 
revealed no differences between phoP-positive and phoP-negative derivatives at 
25°C, but a slightly higher expression in the phoP-positive derivatives at 37°C 
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Y. pseudotuberculosis YPIII, a temperature regulation of csrB could be observed in 
the IP32953 derivatives, which shows a four to five-fold induction at 25°C. 
In addition to the expression analysis of the csrB-lacZ reporter fusion, transcript 
levels of CsrB were compared in the different phoP-positive and phoP-negative 
derivatives. For this purpose, total RNA of exponential grown YPIII and IP32953 was 
isolated and the CsrB transcript was quantified by Northern blotting (Fig. 3.15 B). 
Consistent with the results of the csrB-lacZ reporter gene fusion CsrB levels do not 
differ between phoP-positive and phoP-negative derivatives, neither at 25°C nor at 
37°C.  In contrast, the CsrB transcript is more abundant in IP32953 at 25°C 
compared to 37°C and shows the same temperature-dependency as the β-
galactosidase activity of the csrB-lacZ reporter gene fusion (Fig. 3.15).  
 
 
Fig. 3.15 PhoP-dependent expression of csrB.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C or 37°C as indicated. (A) The β-
galactosidase activity of a csrB-lacZ (pAKH101) fusion was determined. The data represent the mean 
± SEM of three independent experiments performed in triplicates. Data were analyzed by Student’s t-
test (*, P<0.05; **, P <0.01; ***, P <0.001; n.s. – not significant). (B) Total RNA was extracted, 
separated on 1.2% MOPS agarose gels and analyzed by Northern blotting with CsrB-specific probes. 
YP69 (ΔcsrB) was used as negative control, 16S rRNA and 23S rRNAs served as loading controls. 
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A comparison of the β-galactosidase activity of a csrC-lacZ fusion in the respective 
phoP-positive and phoP-negative derivatives revealed a significant increase at 25°C 
and 37°C in the phoP-positive derivatives (Fig. 3.16 A). The CsrC transcript levels 
confirm the data of the β-galactosidase assay; less CsrC is detectable in the 
derivatives harboring a truncated phoP (Fig. 3.16 B). Obviously, the β-galactosidase 
activity of YPIII (phoP-) and IP32953 (phoP-) is similar, while the amount of CsrC 
much higher in YPIII (phoP-). This indicates that the stability of CsrC is different in the 
two clinical isolates. 
 
 
Fig. 3.16 PhoP activates csrC expression in Y. pseudotuberculosis.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C or 37°C. (A) The β-galactosidase 
activity of a csrC-lacZ (pAKH103) fusion was determined. The data represent the mean ± SEM of 
three independent experiments performed in triplicates. Data were analyzed by Student’s t-test (*, 
P<0.05; **, P <0.01; ***, P <0.001). (B) Total RNA was extracted, separated on 1.2% MOPS agarose 
gels and analyzed by Northern blotting with CsrC-specific probes. YP126 (ΔcsrC) was used as 
negative control, 16S rRNA and 23S rRNA served as loading controls. 
 
In summary, the data show that PhoP activates rovA expression via the CsrC-RovM 
regulatory cascade and does not affect crp and csrA expression. 
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3.2.1.4 PhoP binds directly to the regulatory region of csrC 
The two-component system BarA/UvrY is known to directly control the expression of 
the small regulatory RNA csrB, while no transcriptional regulator of csrC was 
identified in Y. pseudotuberculosis so far (Heroven et al., 2008). Therefore, it was 
tested if PhoP directly controls csrC expression. 
Previously, the promoter region of csrC was analyzed revealing the transcriptional 
start site (TSS) of csrC as well as the -35 and -10 region of the csrC promoter 
(Heroven et al., 2008). In silico analysis of the upstream region of csrC revealed two 
putative PhoP-binding sites 32 nucleotides and 94 nucleotides upstream of the TSS.  
To test if PhoP binds to the upstream region of csrC, gel retardation assays were 
performed. For this purpose, three different fragments were analyzed. One fragment 
contains both putative PhoP-boxes (position +93 to -297 relative to the TSS (+1)). 
The two other fragments comprise only one of the two putative binding sites (position 
+93 to -76 and -55 to -297, respectively) (Fig. 3.17). 
 
 
Fig. 3.17 Schematic overview of the csrC upstream region.  
The transcriptional start site of csrC is indicated with +1, grey boxes represent the putative PhoP 
binding sites. The position of the fragments used for gel retardation assays are shown by vertical 
arrows with respect to the transcriptional start site of csrC.  
 
Increasing amounts of purified His6-PhoP protein were incubated with the different 
fragments of the csrC upstream region and gyrA as control fragment (Fig. 3.18). A 
retardation of the DNA-fragment containing both putative PhoP-boxes was observed, 
indicating the formation of a DNA-PhoP complex, whereas no binding was detectable 
to the negative control gyrA (Fig. 3.18 A). Additionally, a dissociation constant (Kd) of 
1.7 µM was determined. In order to test whether csrC harbors one or two PhoP-
binding sites, electrophoretic mobility shift assays were also performed with 
fragments containing either the first or the second putative PhoP-box. For both 
fragments a specific shift of csrC was observed, which indeed indicates the presence 
csrC5’ 3’
+93-297 -76 -55 +1
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of two PhoP-binding sites (Fig. 3.18 B, C). Determination of the Kd reveals a similar 
affinity of PhoP to both binding sites with about 3.3 µM for the first binding site and 
3.9 µM for the second one. To validate this, a competitive electromobility shift assay 
was performed, in which both DNA-fragments with single binding sites were 
incubated simultaneously with PhoP (Fig. 3.18 D). In consistency with the Kd values, 
PhoP binds with the same affinity to both DNA-fragments . 
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Fig. 3.18 PhoP binds to the regulatory region of csrC.  
Increasing concentrations of purified His6-PhoP were incubated with different fragments of the 
proximal region of csrC and separated on 5% polyacrylamide gels. The PhoP-DNA complexes are 
marked with an asterisk. gyrA was used as negative control (c). The csrC fragments were the 
following: (A) -297 to +93, containing both putative PhoP-boxes, (B) -297 to -55, containing the first 
putative PhoP-box and (C) -76 to +93, containing the second PhoP-box. The Kd values were 
determined densiometrically and show the mean ± SEM from three independent experiments. (D) 
Competitive assay with the csrC fragments from region -297 to -55 and -76 to +93. 
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To get further information about the precise binding sites of PhoP, DNaseI 
footprinting experiments were performed. For this purpose, increasing amounts of 
purified His6-PhoP protein were incubated with the regulatory region of csrC, 
subsequently digested with DNaseI and separated on a 6% polyacrylamide gel 
(Fig. 3.19). Usually, binding of protein to the DNA results in a protection from the 
DNaseI digestion in the specific binding region. For both analyzed strands two 
protected regions are visible, reaching from position -112 to -85 and -39 to -19 for the 
sense strand and from position -112 to -85 and -49 to -18 for the anti-sense strand 
relative to the TSS (Fig. 3.19 A, B). Within the protected regions some nucleotides 
became hypersensitive against DNaseI, which is most probably caused by 
conformational changes of the DNA through binding of PhoP. The DNaseI 
footprinting reaction was repeated with the anti-sense strand after pre-incubation of 
PhoP with acetyl phosphate for 30 min (Fig. 3.19 C). Phosphorylation led to a more 
efficient binding of PhoP especially to the first binding site (position -49 to -18). 
Taken together, the data reveal direct and specific binding of PhoP to two distinct 
sites of the csrC proximal region.  
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Fig. 3.19 DNase I footprint of PhoP with the regulatory region of csrC.  
Increasing concentrations of purified His6-PhoP were incubated with the proximal region of the sense 
(A) and anti-sense (B) strand of DIG-labeled csrC, digested with DNaseI and separated on 6% 
polyacrylamide gels. The DNaseI protected regions are marked with vertical bars, hypersensitive 
regions are indicated by asterisks. The numbers represent the nucleotide position upstream of csrC, 
the lanes T, C, A, G designate the Sanger sequencing reactions. (C) DNaseI footprinting reaction of 
the anti-sense strand after pre-incubation of PhoP with 20 mM acetyl phosphate for 30 min at 25°C. 
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3.2.1.5 PhoP-dependent synthesis of two CsrC transcripts  
The TSS of csrC was already mapped 2008 by Heroven et al. in 
Y. pseudotuberculosis YPIII. Here, the TSS was investigated in the phoP-positive 
and phoP-negative derivatives of Y. pseudotuberculosis YPIII (Nuss and Schuster et 
al., 2014). The data confirmed the identified TSS, but an additional TSS was found 
61 nt further upstream. Additionally, putative promoter sequences with PhoP binding 
sites located in close proximity were identified upstream of the two TSSs (Nuss and 
Schuster et al., 2014).  
The two different TSSs led to the assumption that csrC is transcribed from two 
different promoters, leading to two distinct CsrC transcripts. In order to confirm this 
hypothesis, a high-resolution Northern blot was performed with the respective phoP-
positive and phoP-negative derivatives of Y. pseudotuberculosis YPIII and IP32953 
(Fig. 3.20). In fact, two CsrC transcripts were identified in the phoP-positive 
derivatives of YPIII and IP32953. In the phoP-negative derivative of 
Y. pseudotuberculosis YPIII only the shorter transcript is visible, while in the phoP-
negative derivative of IP32953 no CsrC was detectable.  
 
 
Fig. 3.20 High resolution Northern blot of CsrC.  
The Y. pseudotuberculosis strains YPIII and IP32953 and their respective phoP-positive and phoP-
negative derivative were grown to exponential growth phase at 25°C and samples were taken. RNA 
was extracted, separated on a high-resolution urea-polyacrylamide gel and analyzed by Northern 
blotting with CsrC specific probes. YP126 (ΔcsrC) was used as negative control (c – loading control). 
 
3.2.1.6 An insertion of 20 nucleotides is responsible for a decreased CsrC 
transcript stability in Y. pseudotuberculosis IP32953 
Previous results indicated a difference in the stability of CsrC in 
Y. pseudotuberculosis YPIII and IP32953 (see Fig. 3.16). Furthermore, a sequence 
alignment of csrC in different Y. pestis and Y. pseudotuberculosis strains revealed an 
additional 20 nucleotide stretch in csrC of Y. pseudotuberculosis IP32953, which is 
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not present in the other Yersinia strains and probably the result of two duplication 
events.  
In order to prove the hypothesis that the stability of CsrC is reduced in 
Y. pseudotuberculosis IP32953 compared to YPIII, a CsrC stability assay was 
performed (Fig. 3.21). For this purpose, csrC of YPIII and IP32953 was inserted into 
strain YP285 (YP149 ΔcsrC), generating strains YP308 and YP307, respectively. 
Y. pseudotuberculosis YP285 harbors a functional phoP and accomplishes full 
expression of csrC. Moreover, the additional 20 nucleotides of Y. pseudotuberculosis 
IP32953 csrC were inserted into csrC of YPIII, yielding Y. pseudotuberculosis YP306. 
The different strains were grown to exponential growth phase at 25°C and 
transcription was blocked by the addition of rifampicin. At certain time points samples 
were taken and analyzed by Northern blotting. The blots revealed a clear reduction in 
CsrCIP32953 stability. The half-life of CsrCYPIII is approximately 90 min, while 
CsrCIP32953 has a half-life of only 42 min. The insertion of the 20 nucleotide stretch in 
strain YP306 harboring csrCYPIII + 20 nt IP32953 led to an enhanced degradation rate, 
which results in a half-life similar to CsrCIP32953 of about 42 min. 
To conclude, CsrC of Y. pseudotuberculosis IP32953 has a reduced stability 
compared to Y. pseudotuberculosis YPIII, which is caused by an insertion of 20 
nucleotides in Y. pseudotuberculosis IP32953. 
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Fig. 3.21 RNA stability assay of CsrC.  
(A) Y. pseudotuberculosis strains YP308 (csrCYPIII), YP307 (csrCIP32953) and YP306 (csrCYPIII+20nt IP32953) 
were grown to exponential growth phase at 25°C and transcription was stopped by the addition of 
2 mg/ml rifampicin. Samples were taken after 0, 15, 30, 45, 60, 90 and 120 min. RNA was extracted, 
separated on 1.2% MOPS agarose gels and Northern blotting was performed with CsrC-specific 
probes. YP126 (ΔcsrC) was used as negative control, 16S and 23S rRNAs served as loading controls. 
(B) The half-life of CsrC was measured in the strains YP308 (csrCYPIII), YP307 (csrCIP32953) and YP306 
(csrCYPIII+20nt IP32953). The data show the mean ± SEM from three independent experiments. 
 
3.2.2 PhoP affects bistable rovA expression 
To further investigate the effect of PhoP on bistable rovA expression in the different 
Y. pseudotuberculosis isolates YPIII and IP32953 and compare them with their 
respective isogenic phoP-positive and phoP-negative mutants, flow cytometry 
analysis and Western blots were performed at different temperatures. To do so, 
plasmid pKH70 (ProvA-egfpLVA) was transformed into the different strains and cells 
were grown to exponential growth phase. Comparing YPIII (phoP-) and its cognate 
derivative YPIII (phoP+) revealed RovA-dependent egfpLVA expression at higher 
temperatures in YPIII (phoP+) (Fig. 3.22 A, B). A similar, but even more pronounced 
effect can be seen in the IP32953 strain (Fig. 3.22 C, D). egfpLVA is expressed at 
higher temperatures in the phoP-positive derivative of IP32953, while RovA-
dependent egfpLVA expression is strongly diminished in IP32953 (phoP-). 
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In summary, PhoP as new factor controlling bistable rovA expression independently 
of temperature could be identified. 
 
 
Fig. 3.22 PhoP-dependent ProvA-egfpLVA expression.  
Y. pseudotuberculosis YPIII (phoP-) (A), YPIII (phoP+) (B), IP32953 (phoP+) (C), IP32953 (phoP-) (D) 
harboring plasmid pKH70 (ProvA-egfpLVA) were grown to exponential growth phase and samples were 
taken at indicated temperatures for flow cytometry and Western blot analysis. Upper panels show 
quantification of eGFP-positive and eGFP-negative cells measured by flow cytometry. The data show 
the mean ± SEM of three independent experiments performed in duplicates or triplicates. Lower 
panels show Western blots of chromosomally encoded RovA using a RovA specific antibody (c – 
loading control). 
 
3.3 Analysis of bistable rovA expression in the mouse model 
Since no expression of rovA could be observed in Y. pseudotuberculosis YPIII at 
37°C under in vitro conditions, it was tested whether rovA is actually expressed in the 
host and if this expression is heterogeneous. Previously, it was reported that invA is 
expressed three days post infection (Pisano et al., 2012), which indicates that rovA 
might be also active during infection. The mouse model was used to characterize the 
expression of rovA under in vivo conditions. 
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3.3.1 Expression of Ptet-mCherry is suitable for investigations in combination 
with ProvA-egfpLVA 
In order to analyze rovA expression in infected organs and to detect bacteria within 
colonized tissue an adequate reporter system had to be constructed. For this 
purpose plasmid pFS48, for constitutive expression of mCherry under the Ptet 
promoter, was constructed and tested for mCherry expression at different 
temperatures. No temperature-dependent expression of Ptet-mCherry was observed 
(Fig. 3.23 A, B). Ptet-mCherry was expressed within the entire population and the 
fluorescence intensity was very high under all tested conditions. Additionally, 
expression of Ptet-mCherry should not affect RovA-dependent egfpLVA expression. 
The constitutive expression of mCherry might be energy consuming and could 
influence the expression pattern of ProvA-egfpLVA. Also an interference of emission 
and/or excitation spectra of mCherry and eGFP could affect bistable ProvA-egfpLVA 
expression. Therefore, bistable rovA expression was investigated in 
Y. pseudotuberculosis YPIII harboring the two plasmids pKH70 (ProvA-egfpLVA) and 
pFS48 (Ptet-mCherry) (Fig. 3.23 C, D). Flow cytometry revealed that bistability of 
RovA is not affected by constitutive mCherry expression. Two distinct subpopulation 
can be observed between 30°C and 34°C, similar to Y. pseudotuberculosis YPIII 
harboring just pKH70 (ProvA-egfpLVA) (Fig. 3.23 C, Fig 3.1 B). Also the RovA protein 
amount correlates with RovA-dependent egfpLVA pattern (Fig 3.23 D). Therefore, the 
combination of pFS48 (Ptet-mCherry) and pKH70 (ProvA-egfpLVA) seems to be suitable 
for further studies of RovA bistability in the mouse model. 
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Fig. 3.23 Constitutively expressed mCherry has no influence on RovA-dependent expression of 
eGFPLVA.  
Y. pseudotuberculosis YPIII harboring plasmids pKH70 (ProvA-egfpLVA) and pFS48 (Ptet-mCherry) was 
grown to exponential growth phase and samples were taken at different temperatures for flow 
cytometry and Western blotting. (A) Quantification of mCherry-positive and mCherry-negative cells at 
indicated temperatures measured by flow cytometry. The data show the mean ± SEM of one 
experiment performed in triplicates. (B) Intensity of mCherry fluorescence at different temperatures is 
shown in a histogram. All cells express mCherry with a high intensity. (C) Quantification of eGFP-
positive and eGFP-negative cells at indicated temperatures measured by flow cytometry. The data 
show the mean ± SEM of one experiment performed in triplicates. (D) Whole cell extracts were 
prepared, separated on 15% SDS-polyacrylamide gels and RovA expressed from the chromosomal 
rovA gene was analyzed by Western blotting with a RovA specific antibody (c – loading control). 
 
3.3.2 Expression of rovA in vivo  
In order to test if rovA is expressed in vivo, cryosections of infected tissue samples 
were prepared. Cryosections do not only allow quantification of rovA expressing 
cells, but further enable the analysis of the precise localization of RovA positive cells 
within tissues. Besides the expression of wild type rovA on single cell level in 
different organs, potential differences of bacteria expressing the different stabilized 
versions of RovA were investigated. For this purpose BALB/c mice were infected 
orally with 2x108 bacteria of Y. pseudotuberculosis YPIII (wt) or YP287 (RovAP98S, 
G116A, SG127/128IK) carrying plasmids pKH70 (ProvA-egfpLVA) and pFS48 (Ptet-mCherry). 
Additionally, Y. pseudotuberculosis YPIII harboring only plasmid pFS48 (Ptet-
mCherry) served as negative control to exclude unspecific green fluorescence. 
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Caecum and Peyer’s patches were analyzed three days post infection (Fig. 3.24, 
Fig. 3.25). Bacterial cells were visualized by red fluorescence due to constitutive 
expression of Ptet-mCherry.  
In the cryosections of the Peyer’s patches only very few eGFP-positive cells were 
identified within red fluorescent microcolonies as shown in figure 3.24. Green 
fluorescence was specific for eGFP, as no background fluorescence could be 
observed for Y. pseudotuberculosis YPIII harboring only pFS48 (Ptet-mCherry) 
(Fig. 3.24). This reveals that RovA-dependent egfpLVA expression indeed occurs 
during Peyer’s patch colonization. Moreover, no obvious differences in the amount or 
localization of eGFP-positive cells were observed between Y. pseudotuberculosis 
YPIII (wt) and YP287 (RovAP98S, G116A, SG127/128IK).   
 
 
Fig. 3.24 Heterogeneous expression of ProvA-egfpLVA in Peyer’s patches.  
BALB/c mice were orally infected with 2x108 bacteria of either Y. pseudotuberculosis YPIII wild type 
(wt) or YP287 (RovAP98S, G116A, SG127/128IK) harboring plasmids pFS48 (Ptet-mCherry) and pKH70 (ProvA-
egfpLVA). Y. pseudotuberculosis YPIII wt harboring only plasmid pFS48 (Ptet-mCherry) served as a 
control. Three days post infection mice were sacrificed and Peyer’s patches were isolated. 
Cryosections of 6-8 µm were prepared and imaged with a fluorescence microscope. Bacteria were 
visualized by mCherry expression. Green fluorescence indicates bacteria expressing ProvA-egfpLVA. 
DAPI was used for cell nuclei staining. Three mice were analyzed and a representative image is 
shown. White bars indicate 20 µm. 
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Bacteria expressing eGFP under the control of RovA were also identified in the 
caecum three days post infection (Fig. 3.25). While only few eGFP-positive cells 
were visible in the caecum of mice infected with Y. pseudotuberculosis YPIII (wt), a 
considerably higher amount was detectable in YP287 (RovAP98S, G116A, SG127/128IK) 
infected tissue. eGFP-positive bacteria seem to be randomly distributed within 
microcolonies without any obvious spatial preference. 
In order to exclude loss of reporter plasmids during infection, bacteria from infected 
tissues were plated on LB-agar with or without antibiotics. As a result, no plasmid 
loss was detected (Fig. S3). 
 
 
Fig. 3.25 Heterogeneous expression of ProvA-egfpLVA in the caecum.  
BALB/c mice were orally infected with 2x108 bacteria of either Y. pseudotuberculosis YPIII wild type 
(wt) or YP287 (RovAP98S, G116A, SG127/128IK) harboring plasmids pFS48 (Ptet-mCherry) and pKH70 (ProvA-
egfpLVA). As control served Y. pseudotuberculosis YPIII (wt) harboring only plasmid pFS48 (Ptet-
mCherry). Three days post infection mice were sacrificed and the caecum was isolated. Cryosections 
of 6-8 µm were prepared and imaged with a fluorescence microscope. Bacteria were visualized by 
mCherry expression. Green fluorescence indicates bacteria expressing ProvA-egfpLVA. DAPI was used 
for staining the cell nuclei. Three mice were analyzed and a representative image is shown. White 
bars indicate 20 µm. 
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Microscopic observation of the bacteria indicated that more bacteria expressing ProvA-
egfpLVA are located in the caecum of mice infected with Y. pseudotuberculosis YP287 
(RovAP98S, G116A, SG127/128IK) than with YPIII (wt) (Fig. 3.26). In Peyer’s patches of 
Y. pseudotuberculosis YPIII (wt) as well as YP287 (RovAP98S, G116A, SG127/128IK) 
infected mice only very few eGFP-positive cells were found. In the caecum of mice 
infected with Y. pseudotuberculosis YP287 (RovAP98S, G116A, SG127/128IK) approx. 4% of 
all bacteria express egfpLVA in a RovA-dependent manner, while only 0.5% are found 
in Y. pseudotuberculosis YPIII (wt). This reveals a significantly increase of eGFP-
positive cells of about eight-fold through stabilization of RovA.  
 
 
Fig. 3.26 Relative amount of ProvA-egfpLVA expressing cells in caecum and Peyer’s patches. 
The amount of GFP-positive cells was counted and divided by the amount of all cells, which were 
visualized by red fluorescence through mCherry expression. Each dot represents the ratio of eGFP to 
mCherry-positive cells in one picture. Three to 23 pictures were analyzed per mouse; three mice were 
analyzed. The bar indicates the median of the data. Statistics were performed by Student’s t-test with 
***, P <0.001, n.s. - not significant. 
 
In summary, the results show that bistable rovA expression occurs in caecum and 
Peyer's patches of Y. pseudotuberculosis YPIII (wt) and YP287 (RovAP98S, G116A, 
SG127/128IK) three days post infection. Furthermore, stabilization of RovA leads to an 
increase of rovA-expressing bacteria in the caecum. 
 
3.3.3 Bistable rovA expression and its role for virulence  
One major goal of this study was to investigate the role of bistable rovA expression 
on virulence. It was previously shown that a rovA knock-out mutant in 
Y. enterocolitica is highly attenuated in virulence and the LD50 is significantly higher 
than in the wild type (Revell and Miller, 2002). In Y. pseudotuberculosis the rovA 
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deletion mutant does not colonize mice as efficiently as the wild type and 
dissemination to deeper organs such as liver and spleen is diminished (Heroven and 
Dersch, 2006). However, the impact of bistable expression and effect of the 
expression of stabilized variants of RovA on the virulence of Y. pseudotuberculosis 
remains unclear.  
The substitutions of amino acid P98S, G116A and SG127/128IK within the RovA 
protein led to alterations in the bistable expression of rovA in vitro. To assess 
whether the modifications of RovA affect also bacterial pathogenesis, survival and 
organ burden experiments of Y. pseudotuberculosis YP269 (RovAP98S), YP270 
(RovAG116A), YP287 (RovAP98S, G116A, SG127/128IK) expressing different stabilized variants 
of RovA as well as Y. pseudotuberculosis YPIII wild type and YP107 (ΔrovA) were 
investigated in the mouse model.  
For the survival experiment mice were orally infected with 2x108 bacteria and 
survival, bodyweight and general appearance, such as rough fur, were monitored up 
to 15 days and the date of death was recorded (Fig. 3.27). All mice infected with 
Y. pseudotuberculosis YPIII (wt) developed severe symptoms of disease and 
succumbed to infection five to eight days post infection. In contrast, mice infected 
with YP107 (ΔrovA) as well as the stabilized mutants YP269 (RovAP98S), YP270 
(RovAG116A) and YP287 (RovAP98S, G116A, SG127/128IK) remained healthier and differed 
significantly from those infected with the YPIII wild type. Only about 50% of YP107 
(ΔrovA), YP270 (RovAG116A) and YP287 (RovAP98S, G116A, SG127/128IK) infected mice 
displayed symptoms of disease and succumbed to infection, while the remaining 
mice developed only mild symptoms and regained weight after seven to ten days 
post infection. More than 60% of mice challenged with YP269 (RovAP98S) succumbed 
within eleven days post infection and developed severe symptoms similar to the wild 
type.  
Taken together, tight control of the bistable expression of rovA seems to be crucial 
for full virulence of Y. pseudotuberculosis. The stabilization of RovA, which results in 
an increase of RovA positive bacteria, had a similar effect on YPIII virulence as the 
complete loss of RovA.  
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Fig. 3.27 Influence of RovA on the survival of BALB/c mice infected with 
Y. pseudotuberculosis.  
BALB/c mice (n=17-18/strain) were orally infected with 2x108 bacteria of Y. pseudotuberculosis YPIII 
wild type (red line), YP107 (ΔrovA, yellow line) as well as different stabilized RovA mutant strains; 
YP269 (RovAP98S, purple line), YP270 (RovAG116A, green line), YP287 (RovAP98S, G116A, SG127/128IK, blue 
line). Survival (A) and bodyweight (B) were monitored up to 15 days post infection. Data were 
analyzed with log-rank (Mantel-Cox) test and show statistically significant differences between the wild 
type and mutant strains with **, P <0.01; ***, P <0.001. 
 
3.3.4 Organ colonization is attenuated in the different rovA mutants 
To determine the effect of stabilized RovA during the course of infection and identify 
differences in the bacterial load of the organs, colonization properties of the mutants 
were investigated. Therefore mice were orally infected with 2x108 CFU of 
Y. pseudotuberculosis YPIII wild type (wt), YP107 (ΔrovA), YP269 (RovAP98S), YP270 
(RovAG116A) or YP287 (RovAP98S, G116A, SG127/128IK) and Peyer’s patches, caecum, 
mesenteric lymph nodes (MLNs), liver and spleen were isolated one, three and five 
days post infection. The organs were homogenized, plated on LB and the CFUs were 
calculated per gram of tissue (Fig. 3.28, 3.29, 3.30). 
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Fig. 3.28 Organ colonization of BALB/c mice one day after infection with 
Y. pseudotuberculosis.  
BALB/c mice (n=10/strain) were orally infected with 2x108 bacteria of Y. pseudotuberculosis YPIII wild 
type (wt), YP107 (ΔrovA) as well as YP269 (RovAP98S), YP270 (RovAG116A) and YP287 (RovAP98S, 
G116A, SG127/128IK). One day post infection the number of bacteria in Peyer’s patches, caecum, MLNs, 
liver and spleen were determined by plating. The dots represent the CFU per gram tissue of one 
mouse; lines illustrate the medians. Data were analyzed with Mann-Whitney test and show statistically 
significant differences between the wild type and mutant strains with *, P<0.05; **, P <0.01; ***, P 
<0.001. 
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One day post infection Peyer’s patches are highly colonized by 
Y. pseudotuberculosis YPIII (wt), YP269 (RovAP98S) and YP270 (RovAG116A), while a 
significantly lower bacterial load was detectable in mice infected with YP107 (ΔrovA) 
and YP287 (RovAP98S, G116A, SG127/128IK) (Fig. 3.28). All tested mutants were 
significantly impaired in colonization of the caecum, while the strongest attenuation 
was observed for YP107 (ΔrovA) and YP287 (RovAP98S, G116A, SG127/128IK). At day one 
post infection only few bacteria could be recovered from MLNs, liver and spleen.  
Three days post infection differences in the organ colonization between 
Y. pseudotuberculosis YPIII (wt) and the RovA mutants were pronounced (Fig. 3.29). 
Strain YP107 (ΔrovA) is attenuated in host invasion, replication within Peyer’s 
patches and dissemination to deeper organs. The bacterial load in the organs of mice 
infected with strain YP287 expressing the most stabilized RovA variant is comparable 
to the ΔrovA mutant; Peyer’s patches, caecum, MLNs and spleen show a 
significantly lower colonization than the wild type. All tested mutants affect the 
colonization of MLNs as a significantly lower bacterial load was determined in all 
strains in comparison to the wild type. 
Consistent with the survival experiment, stabilization of RovA has a similar negative 
effect on host colonization efficiency as the deletion of rovA. 
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Fig. 3.29 Organ colonization of BALB/c mice three days after infection with 
Y. pseudotuberculosis.  
BALB/c mice (n=10/strain) were orally infected with 2x108 CFU of Y. pseudotuberculosis YPIII wild 
type (wt), YP107 (ΔrovA) as well as YP269 (RovAP98S), YP270 (RovAG116A) and YP287 (RovAP98S, 
G116A, SG127/128IK). Three days post infection the number of bacteria in Peyer’s patches, caecum, MLNs, 
liver and spleen were determined by plating. The dots represent the CFU per gram tissue of one 
mouse; lines illustrate the medians. Data were analysed with Mann-Whitney test and show statistically 
significant differences between the wild type and mutant strains with *, P<0.05; **, P <0.01; ***, P 
<0.001. 
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At day five post infection differences in the colonization are no longer visible 
(Fig. 3.30). Only Peyer’s patches and spleen show a lower bacterial load of YP107 
(ΔrovA) than YPIII (wt). This indicates that the negative impact of a rovA knock-out 
mutant and stabilized RovA mutants is eliminated after several days of infection and 
most likely delayed compared to the wild type. Interestingly, although no differences 
in the colonization were detectable five days post infection; the survival rates differed 
significantly between the strains.  
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Fig. 3.30 Organ colonization of BALB/c mice five days after infection with 
Y. pseudotuberculosis.  
BALB/c mice (n=10/strain) were orally infected with 2x108 CFU of Y. pseudotuberculosis YPIII wild 
type (wt), YP107 (ΔrovA) as well as YP269 (RovAP98S), YP270 (RovAG116A) and YP287 (RovAP98S, 
G116A, SG127/128IK). Five days post infection the number of bacteria in Peyer’s patches, caecum, MLNs, 
liver and spleen were determined by plating. The dots represent the CFU per gram tissue of one 
mouse; lines illustrate the medians. Data were analysed with Mann-Whitney test and show statistically 
significant differences between the wild type and mutant strains with *, P<0.05; **, P <0.01; ***, P 
<0.001. 
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4 Discussion 
Pathogenic bacteria are often confronted with fast changing environmental 
conditions, e.g. switching between environmental lifestyles and host colonization. In 
this process, bacteria have to rapidly adapt their gene expression pattern in order to 
be competitive with other microorganisms, to avoid recognition by the host immune 
system, to optimize their fitness and to save energy expenses (Straley and Perry, 
1995). To this purpose, several mechanisms on transcriptional, post-transcriptional, 
translational and post-translational level have been evolved to rapidly regulate gene 
expression. However, pre-adaptation of a subset of the population to certain 
conditions might be even more advantageous in order to survive under sudden 
changes and environmental uncertainty, increasing the fitness of a species. This pre-
adaption is accomplished via phenotypic heterogeneity. Phenotypic heterogeneity is 
a widespread phenomenon in bacteria that describes two or more cell types within 
one population and can arise through epigenetic changes and certain gene 
regulatory circuits. A special type of phenotypic heterogeneity is bistability, which is 
characterized by the bifurcation of one bacterial population into distinct 
subpopulations only by changes on transcriptional level without any mutations or 
DNA-rearrangements (Dubnau and Losick, 2006). A well-known example of 
bistability is described for sporulation in B. subtilis. Under nutrient-limiting conditions, 
Spo0A, the master regulator of sporulation, is activated by phosphorylation via a 
phosphorelay (Errington, 1993). The phosphorylation of Spo0A as well as the 
transcription of spo0A are under positive auto-regulatory control and were shown to 
be responsible for the heterogeneous phenotype in a sporulating culture (Strauch et 
al., 1992; Veening et al., 2005). The benefit of bistability is survival of a population 
during harsh conditions (bet-hedging) and an increased fitness of a population by 
divison of labor (Veening et al., 2008a).  
In this study the bistable expression of the virulence regulator RovA of 
Y. pseudotuberculosis was examined. The mechanisms underlying rovA bistability as 
well as factors involved in formation of bistability were analysed. Moreover, the 
contribution of bistable rovA expression to virulence was investigated. 
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4.1 Bistability of RovA is characterized by a temperature-inducible 
switch 
Temperature is one of the most important signals pathogenic bacteria monitor in 
order to adjust their virulence gene expression patterns. Therefore, it is not surprising 
that thermosensors on DNA, RNA and protein level evolved to sense temperature 
fluctuations via conformational changes (Klinkert and Narberhaus, 2009; Steinmann 
and Dersch, 2013). The nucleoid-associated protein H-NS was found to act on DNA 
topology, thereby affecting temperature-dependent transcription of target genes: 
expression of virF of Shigella flexneri is inhibited by DNA-bending at temperatures up 
to 32°C. At temperatures below 32°C H-NS interacts with two H-NS binding sites 
within the virF promoter and prevents transcription initiation. At higher temperatures 
the bent DNA opens up and as a result the transcriptional activator FIS can bind and 
activate virF transcription (Falconi et al., 1998; Prosseda et al., 2004). Temperature-
dependent expression of the DNA-binding protein LcrF of Y. pseudotuberculosis is 
regulated on RNA level (Böhme et al., 2012; Hoe et al., 1992; Skurnik and Toivanen, 
1992). At moderate temperature, the intergenic region of the polycistronic yscW-lcrF 
mRNA forms secondary structures that prevent binding of ribosomes through 
masking the ribosomal binding site. At host body temperature (37°C) the secondary 
structure melts and binding of ribosomes is enabled (Böhme et al., 2012). Moreover, 
the transcriptional repressor TlpA of S. enterica serovar Typhimurium was shown to 
be a protein thermometer that forms coiled-coil homodimers at moderate 
temperatures, while a temperature increase to 37°C leads to a dissociation into non-
functional monomers (Hurme et al., 1997). Also RovA of Y. pseudotuberculosis was 
shown to act as a thermosensor by altering its conformation (Herbst et al., 2009). At 
host body temperature (37°C) the DNA-binding capacity of RovA is reduced. In this 
process, amino acids of the central DNA-binding domain are exposed, which are 
recognized by Lon and Clp proteases, leading to enhanced degradation of RovA 
(Herbst et al., 2009). Expression of rovA was further shown to be regulated by a 
positive and a negative feedback loop as well as cooperative binding (Heroven et al., 
2004). Additionally, it was described previously that DNA-binding and proteolysis are 
temperature-dependent (Herbst et al., 2009; Quade et al., 2012).  
In this study it was demonstrated that rovA is bistably expressed in a temperature-
dependent manner. At moderate temperature the DNA-binding affinity of RovA is 
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high, while the degradation rate is low. As a consequence rovA is expressed in all 
cells within the entire bacterial population. A shift to 37°C decreases the DNA-binding 
affinity and enhances proteolysis reducing the overall amount of active RovA in the 
bacteria. Experiments following RovA expression in the population on single cell level 
demonstrated bistable rovA expression within a certain temperature range (30°C to 
33°C). This led to the formation of RovA-positive and RovA-negative subpopulations. 
A mathematical modeling approach was used to describe the parameters involved in 
the establishment of bistable rovA expression and is given by a differential equation 
for the temporal change of RovA concentration in response to temperature (Fig. S4, 
Müller, J.; Münch, R.). The developed mathematical model predicted that the 
molecular determinants underlying the formation of two subpopulations at 
intermediate temperature are mainly the positive feedback loop and non-linear 
response of cooperative binding, which lead to an enormous increase of RovA 
amount in the cell and thereby reaching a critical threshold, which results in 
expression of rovA. A second important determinant for the establishment of bistable 
rovA expression is proteolysis, which leads to a fast degradation of RovA in the cell 
and thereby to a RovA-negative population. Thus, the modeling predicts two 
subpopulations with either high or low rovA expression dependent on the 
temperature. 
Until now, no other temperature-tunable bistable switch was described in bacteria. 
The bistable expression of other regulators is mostly dependent on the growth phase 
or on the nutrient availability of the surrounding medium. For instance, expression of 
virulence genes of Vibrio cholerae, encoding the toxin-coregulated pilus and the 
cholera toxin, were shown to be bistable during entry into stationary phase (Nielsen 
et al., 2010). Phenotypic heterogeneity was also reported for Salmonella in host 
tissues through the formation of non-replicating persister cells, which are more 
tolerant to antibiotic treatment (Claudi et al., 2014; Helaine et al., 2014). This form of 
pathogen specialization indicates the importance of phenotypic heterogeneity also for 
virulence and demonstrates new challenges in disease control. 
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4.2 Autoregulation, proteolysis and DNA-binding contribute to 
bistable rovA expression 
Time-lapse microscopy, which monitored the switching process of cells from the “ON” 
(rovA expression) to the “OFF” (no rovA expression) state and vice versa, revealed 
hysteresis of bistable rovA expression. In this process, bacterial cells tend to remain 
in the same state as the ancestor cell (Ninfa and Mayo, 2004; Veening et al., 2008a). 
Hysteresis of bistable rovA expression was also confirmed by temperature up- and 
downshifts in bioreactor experiments (Nuss, A. M.; Bücker, R., unpublished data). 
Switching of the bacteria from the “ON” to the “OFF” state after a rapid temperature 
shift from 25°C to 37°C was fast, after three to four hours all bacteria were in the 
“OFF” state. The reverse switch was slow and even after eighteen hours at 25°C still 
one third of the bacterial population remained in the “OFF” state (Nuss, A. M.; 
Bücker, R., unpublished data). The mathematical model can be used to explain the 
mechanisms causing hysteresis. The model predicts that the net production rate of 
RovA in the cell tends to be zero at 37°C (Müller J.; Münch R., unpublished data). 
This explains the very slow “ON” switch after a temperature downshift, as possibly 
only stochastic fluctuations in basal gene expression are the main trigger for 
production of critical RovA amounts until a threshold is reached, which in turn lead to 
an “ON” switch. The rapid “OFF” switch is caused by an immediate stop of rovA 
transcription due to conformational changes of the RovA protein, which lead to 
reduced DNA-binding affinity and increased degradation of RovA (Herbst et al., 
2009). A decreased production rate in combination with enhanced proteolysis seems 
to be the main effector for the fast “OFF” switch. 
In order to get information about the molecular mechanisms underlying bistable rovA 
expression and confirm the prediction of the mathematical model that proteolysis is 
crucial for bistable rovA expression, mutations were introduced in the rovA gene 
leading to RovA variants with amino acid exchanges of P98S, G116A and 
SG127/128IK. These amino acid substitutions lead to stabilized RovA variants with 
enhanced DNA-binding affinity at 37°C and decreased proteolysis at 37°C. Data of 
this study demonstrated that in the mutants, expressing stabilized RovA variants, 
bistable rovA expression shifted to higher temperatures and occurs in a broader 
temperature range. Still, a stabilization of RovA due to exchange of the amino acids 
P98S, G116A and SG127/128IK do not lead to abrogation of bistability. As predicted 
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in the mathematical model, only extremely high or low degradation and production 
rates are able to abolish bistable rovA expression (Müller J.; Münch R., unpublished 
data). This indicates that bistable rovA expression is very robust to perturbations and 
the introduced amino acid exchanges of P98S, G116A and SG127/128IK are not 
sufficient to totally block proteolysis of RovA.  
Furthermore, the mathematical model predicted that the positive feedback loop is the 
main requirement for the formation of bistable rovA expression (Müller J.; Münch R., 
unpublished data). To investigate experimentally the impact of the autoregulatory 
loops on bistable rovA expression, stabilized RovAP98S, G166A, SG127/128IK was expressed 
under the control of a constitutive promoter. The data demonstrated that the 
autoregulation has a high impact on bistable expression of rovA, but also show that 
bistable rovA expression can still be observed, especially at higher temperatures 
(34°C to 37°C). At host body temperature (37°C) only approximately 20% of the 
population are RovA-positive. The bistable expression of rovA even under the control 
of a constitutive promoter is caused by the remaining proteolysis of RovA, which is 
enhanced at 37°C. Moreover, expression of lon is temperature-dependent. At 37°C, 
significantly higher amounts of Lon protease are present compared to 25°C (Herbst 
et al., 2009). Apart from temperature-dependent proteolysis of RovA, it is possible 
that the synthesis of RovA is temperature-dependent through so far unknown factors. 
The influence of the autoregulatory loop was also described in other bistable 
systems, which are not temperature regulated, e.g. ComK of B. subtilis. The 
transcriptional regulator ComK is responsible for the appearance of bistability during 
competence development (Smits et al., 2005). By un-coupling the expression of 
comK from positive autoregulation with an inducible promoter, bifurcation into two 
subpopulations was fully abolished (Smits et al., 2005). This confirms that bistability 
of RovA is not only caused by the autoregulatory loop, but also by proteolysis or 
additional unknown factors. 
 
4.3 Fine-tuning of the RovA bistable switch by environmental 
factors 
The bistable expression of rovA was demonstrated to be mainly promoted by 
proteolysis and autoregulation, which are both temperature-dependent. Besides 
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temperature, also nutrients, pH and ion concentrations are crucial signals pathogenic 
bacteria sense in order to adapt their gene expression pattern. The two-component 
system PhoP/PhoQ is one of the main transduction systems involved in virulence of 
many pathogenic bacteria like Salmonella, Mycobacterium and Yersinia and senses 
low Mg2+-concentrations, antimicrobial peptides and acidic pH (Grabenstein et al., 
2004; Miller et al., 1989; Pérez et al., 2001). Data of the present study reveals a 
connection of PhoP with the virulence regulator RovA. The analysis of different phoP-
positive and phoP-negative Y. pseudotuberculosis strains demonstrated that PhoP 
activates rovA expression through the non-coding RNA CsrC. PhoP positively affects 
csrC expression by direct binding to two distinct binding sites within the regulatory 
region of csrC, identifying the first transcriptional regulator of csrC in 
Y. pseudotuberculosis. So far, only factors indirectly controlling csrC expression were 
described. For instance, Crp positively regulates CsrC by acting indirectly via the 
other Csr-type regulatory RNA CsrB, which occurs mainly through counter-regulation 
of the two non-coding RNAs, and a CsrB-independent mechanism (Heroven et al., 
2012a). Moreover, Hfq indirectly activates csrC expression on transcriptional level, 
while the Yersinia modulator protein YmoA stabilizes CsrC (Böhme, K., PhD thesis). 
In other bacterial species e.g. E. coli or Salmonella, both small regulatory RNAs are 
regulated by the BarA/UvrY or BarA/SirA two-component system, respectively, 
whereas in Yersinia only csrB is regulated by BarA/UvrY (Chavez et al., 2010; 
Heroven et al., 2008; Martínez et al., 2014). For V. cholerae three non-coding RNAs 
are described, which are all controlled by the homologues two-component system 
VarS/VarA and redundantly expressed (Lenz et al., 2005). However, the small 
regulatory RNAs RsmY and RsmZ are differentially expressed in Pseudomonas 
aeruginosa. Both RNAs are activated by the two-component system GacA/GacS, 
which is homologous to the BarA/UvrY system, but the output of this activation 
depends on the incoming signal. While RetS activates both RNAs via the two-
component system, HptB activates only rsmY via GacA/GacS through another 
distinct signalling pathway (Bordi et al., 2010). Nevertheless, all known non-coding 
RNAs of the Csr-system, except CsrC of Yersinia, are regulated by the BarA/UvrY 
system (Heroven et al., 2012b). The involvement of two independent signalling 
systems promotes a better fine-tuning of the regulation of virulence factors. The 
inducing signal for BarA/UvrY is unknown in Yersinia, but in E. coli and S. enterica 
serovar Typhimurium BarA is activated by formate, acetate and other short-chain 
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fatty acids (Chavez et al., 2010; Lawhon et al., 2002). These activating metabolites 
are produced by commensal bacteria and are present in the gastrointestinal tract, 
where they probably serve as energy source for Yersinia and other bacteria. Signals 
to activate the two-component system PhoP/PhoQ are low Mg2+- and Ca2+-
concentrations, acidic pH as well as antimicrobial peptides, characteristics of 
professional phagocytes (Groisman, 2001; Groisman and Mouslim, 2006; Véscovi et 
al., 1996). Activated PhoP promotes survival and replication in macrophages by 
activating e.g. Mg2+-transport systems as described for Salmonella and Yersinia (Li 
et al., 2008; Tao et al., 1995; Zhou et al., 2005). As demonstrated in this study, PhoP 
enhances expression of rovA and this might play a role in survival in macrophages. 
Moreover, Crp is involved in the regulation of the Csr-system in 
Y. pseudotuberculosis, which adapts the bacterial metabolism to different sugars 
(Heroven et al., 2012a). In the presence of glucose, a reduction of Crp and cAMP 
levels leads to the inhibition of the catabolism of alternative sugars, while under 
glucose-limiting conditions a Crp-cAMP-complex binds to target DNA and induces 
expression of catabolic pathways of other sugars (Saier, 1998). The different signals 
that are received by the Csr-system demonstrate the high complexity of this system 
and, as it was shown for PhoP, play a role in a fine-tuned bistable expression of 
rovA, which may contribute to the adaption to different niches within the host.  
Furthermore, this study revealed a reduced stability of CsrC of Y. pseudotuberculosis 
IP32953 compared to Y. pseudotuberculosis YPIII. Responsible for this is the 
insertion of a 20 nucleotides stretch in Y. pseudotuberculosis IP32953, which renders 
the transcript more susceptible for degradation by RNases. A decreased stability of 
CsrC in Y. pseudotuberculosis IP32953 leads to a lower transcript level in 
comparison to Y. pseudotuberculosis YPIII, while the presence of PhoP in 
Y. pseudotuberculosis IP32953 results in a higher expression of csrC than in strain 
YPIII. In Y. pseudotuberculosis IP32953 PhoP is crucial for strong rovA expression, 
while PhoP is dispensable in Y. pseudotuberculosis YPIII for full rovA expression. 
The enhanced stability of CsrC in Y. pseudotuberculosis YPIII probably compensates 
the lack of PhoP and leads to a similar amount of RovA at 25°C in both strains. 
Moreover, in the present study it was demonstrated that two CsrC transcripts are 
synthesized dependent on PhoP. While the shorter transcript version is also 
produced in the absence of PhoP, but highly induced in the presence of PhoP, the 
expression of the longer transcript is strongly dependent on PhoP. Structure analysis 
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of the two CsrC transcripts using Mfold revealed no differences in the overall 
structure of CsrC, but an additional hairpin in the longer transcript (Nuss and 
Schuster et al., 2014). The hairpin does not harbour any further GGA-motifs, which 
are preferably bound by CsrA. Thereby, an impact on CsrA by sequestration due to 
this additional hairpin is unlikely. Based on these data, a model for PhoP-dependent 
regulation of csrC is shown in figure 4.1. 
 
 
Fig. 4.1 Model of PhoP-dependent regulation of csrC in Y. pseudotuberculosis and strain-
specific differences. 
In Y. pseudotuberculosis IP32953 PhoP binds to two distinct binding sites in the promoter region of 
csrC and thereby activates expression of csrC. This leads to the synthesis of two CsrC transcripts, a 
shorter and an extended version. A 20 nucleotides stretch (indicated as black box) is responsible for a 
fast degradation of CsrC by RNases. Y. pseudotuberculosis YPIII carries a non-functional PhoP, thus 
csrC expression cannot be activated by PhoP. A so far unknown mechanism leads to transcription of 
csrC, which results in the synthesis of only the shorter CsrC transcript. Since Y. pseudotuberculosis 
YPIII does not harbor the 20 nucleotides stretch, CsrC is less susceptible to degradation. In both 
Y. pseudotuberculosis strains CsrC inhibits CsrA activity, which in turn results in lower RovM-levels 
and increased RovA synthesis. 
 
As PhoP promotes survival and replication in macrophages (Grabenstein et al., 2004; 
Oyston et al., 2000) and controls the expression of the virulence regulator RovA, it is 
intriguing to analyse whether PhoP affects virulence of Y. pseudotuberculosis. 
Several studies regarding the influence of PhoP on virulence have been undertaken. 
A phoP mutant of Y. pestis strain GB has a reduced ability to survive in macrophages 
and is 75-fold less virulent in mice (Oyston et al., 2000). Strikingly, the phoP mutant 
PhoP PhoP 
IP32953 
csrC 
antimicrobial peptides, 
low Mg2+, low Ca2+ 
RNase 
transcription 
CsrA 
RovM 
RovA 
CsrC 
csrC 
? 
transcription 
CsrC 
 
CsrA 
RovM 
RovA 
YPIII 
Discussion  96 
 
of Y. pestis strain CO92 is not attenuated in virulence in mice, even if the survival in 
macrophages was decreased (Bozue et al., 2011). For a phoP mutant in 
Y. pseudotuberculosis 32777 a 100-fold decreased virulence in a murine oral 
infection model was reported (Grabenstein et al., 2004). Pisano et al. (2014) 
investigated the impact of PhoP in the same Y. pseudotuberculosis strains, YPIII and 
IP32953, that were also analyzed in this study. Consistent with previous results, 
survival in macrophages was significantly decreased in the isogenic phoP mutants of 
each strain. However, only a slight increase of the lethality was observed with mice 
infected with Y. pseudotuberculosis YPIII phoP+ but not with IP32953. Overall, only a 
low impact of PhoP on virulence and organ colonization by the two strains was 
detected (Pisano et al., 2014).  
 
4.4 Bistable expression of rovA during infection 
Expression of rovA was previously shown to be temperature-dependent and 
repressed at 37°C (Herbst et al., 2009; Nagel et al., 2001). Flow cytometry data of 
this study also revealed that rovA expression is “OFF” in the whole population under 
in vitro conditions. Hence, it was questionable whether RovA-positive populations 
exist during the course of Yersinia infection. The presented data indeed 
demonstrated expression of rovA in the caecum and Peyer’s patches during acute 
infection. Around 0.5% of the bacterial population is RovA-positive in the caecum, 
while only very few RovA-positive bacteria were found in the Peyer’s patches. 
Temperature-independent factors such as nutrients, ion concentration, pH and 
oxygen concentration most likely contribute to expression of rovA in vivo. For 
instance, RovM was reported to repress rovA expression under nutrient-limiting 
conditions (Heroven and Dersch, 2006), which lead to an abrogation of bistable rovA 
expression. Moreover, it was shown in this study that bistable rovA expression shifts 
to a higher temperature range in the absence of RovM. As the gastrointestinal tract is 
nutrient-rich, a de-repression of rovA expression in the gut might lead to the 
formation of a small subpopulation of RovA-positive cells. Furthermore, it was 
demonstrated that Y. pseudotuberculosis secretes a factor during stationary phase, 
which was shown to enhance stability of RovA at 37°C (Herbst, K., PhD thesis; 
Mendonca, C., PhD thesis). A comparison of the in vivo and in vitro transcriptome of 
Y. pseudotuberculosis YPIII by RNA-seq at different growth phases revealed that the 
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expression pattern in vivo correlates best with gene expression during stationary 
phase (Nuss, A. M., unpublished data). Therefore, it is likely that this factor is 
produced in vivo leading to stabilization of RovA and consequently to a 
subpopulation of RovA-positive cells during infection.  
Initial colonization of the host by enteropathogenic Yersinia occurs through the 
interaction of invasin with β1-integrins on M-cells and further colonization of the 
underlying Peyer's patches (Clark et al., 1998). In a recent study it was described 
that invasion of the Peyer's patches is clonal by one single bacterium (Oellerich et 
al., 2007). By infecting mice with a mixture of green and red fluorescing bacteria it 
was further demonstrated that a microcolony in liver and spleen is either green or red 
indicating a clonal formation of microcolonies (Oellerich et al., 2007). As a 
consequence, formation of either RovA-positive or RovA-negative subpopulations 
most likely occurs after the invasion of the Peyer's patches in a growing microcolony 
and is not the result of heterogenous rovA expression within a bacterial population 
prior to invasion. 
Phenotypic hetereogeneity plays an important role for virulence of pathogenic 
bacteria. Recently, another heterogeneous expression of virulence-associated genes 
was described for Y. pseudotuberculosis in the spleen of infected mice (Davis et al., 
2015). Exterior bacteria of a microcolony express hmp, which encodes a nitric oxide 
dioxygenase, while interior bacteria are hmp-negative. Exterior bacteria are 
surrounded by neutrophils, which release reactive nitrogen species as nitric oxide 
that can be detoxified by the nitric oxide dioxygenase. Moreover, bacteria located 
most peripherally are in direct contract to host cells and express yopE to prevent 
phagocytosis by neutrophils (Davis et al., 2015). This indicates that peripheral and 
interior bacteria of a microcolony respond to different signals dependent on their 
microenvironment (Davis et al., 2015). In contrast, cryo-sections of infected organs 
performed in this study demonstrated that single RovA-positive cells were randomly 
distributed among the RovA-negative population without any preferred site in the 
periphery or centre of a microcolony. Thus, a reaction to different microenvironments 
or host cell contact is rather unlikely. 
The finding that rovA is expressed in the caecum leads to the hypothesis that it might 
help Yersinia to re-infect the host specifically from this organ during persistent 
infections. In this context, the bacteria would need to express rovA in order to 
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activate invA expression. In accordance with these observations, Fahlgren et al. 
(2014) identified the caecum as primary colonization site of Y. pseudotuberculosis 
during persistence. By using a sublethal infection dose, bacterial colonization of the 
caecum and in rare cases of Peyer’s patches could be detected in infected but 
asymptomatic mice, indicating a persistent infection. As Y. pseudotuberculosis 
infections occur via the faecal-oral route, persistence in the gastro-intestinal tract is 
advantageous, because bacteria can spread by faecal shedding (Avican et al., 2015; 
Fahlgren et al., 2014). Therefore, expression of rovA in a subpopulation of cells might 
prepare a subset of the bacteria for better survival within the gut and enhance re-
infection and/or shedding, which would support infection of a new host. Moreover, in 
vivo RNA-seq of bacteria during colonization of the caecum at early and persistent 
infection stages revealed a distinct transcriptional pattern (Avican et al., 2015). The 
transcriptome during the persistent stage resembles the pattern observed at 26°C 
under in vitro conditions. While genes of the T3SS were down-regulated, an up-
regulation of flagella genes, invA as well as rovA was monitored (Avican et al., 2015). 
In the persistent stage of infection, temperature is no longer the main environmental 
signal to adjust gene expression. More likely, low oxygen concentrations as well as 
oxidative and acidic stress seem to be crucial signals, as related genes were 
significantly up-regulated (Avican et al., 2015). Bacteria in the persistent stage are 
often surrounded by polymorphonuclear neutrophils, which may trigger the activation 
of genes involved in protection against oxidative and acidic stress as well as limited 
oxygen concentrations (Avican et al., 2015; Fahlgren et al., 2014). Therefore, it is 
conceivable that bistable expression of rovA not only contributes to invA expression 
to mediate re-infection of the host, but is further involved in the regulation of genes 
important to ensure survival during persistence.  
Interestingly, the central regulator of biofilm formation CsgD in S. enterica serovar 
Typhimurium, which was shown to be bistably expressed, seems also important for 
persistence in the environment (Grantcharova et al., 2010; MacKenzie et al., 2015). 
In a liquid culture grown under biofilm-inducing conditions, the population bifurcates 
into aggregated and planktonic cells due to the differential expression of csgD 
(Grantcharova et al., 2010). It is assumed, that the planktonic cells are primed for 
host cell invasion, while the multicellular aggregates prepare persistence outside the 
host (MacKenzie et al., 2015). A similar mechanism is feasible for bistable 
expression of rovA. A small subset of RovA-positive cells might already prepare the 
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bacteria for the persistent infection stage, while the majority of cells, the RovA-
negative subpopulation, expresses genes important for the defense of the host 
immune system during the acute infection phase such as the T3SS. Future 
experiments are directed to test whether rovA is expressed in a bistable manner 
during the persistent stage of infection and is indeed involved in the establishment of 
long-term infections.  
Besides host mammalian colonization, bistable expression of rovA could also 
contribute to survival in invertebrates. It is well-known that Y. pestis colonizes insects 
such as the flea, which serves as a transmission vector to infect the human host 
(Perry and Fetherston, 1997). For instance, in Y. pestis expression of phoP, which 
activates the CsrA-RovM-RovA cascade is up-regulated in fleas during transition to 
warm-blooded hosts, which is believed to prepare the bacteria against attacks of the 
human immune system (Vadyvaloo et al., 2010). Also the enteropathogenic Yersinia 
species are able to colonize insects like flies (Rahuma et al., 2005; Zurek et al., 
2000, 2001). Some of the Y. enterocolitica and Y. pseudotuberculosis strains carry a 
tc (toxin complex) gene cluster on a tc pathogenicity island (Fuchs et al., 2008). Tc 
proteins were first identified in the Gram-negative bacterium Photorhabdus 
luminescens and reported to have an insecticidal activity (Bowen and Ensign, 1998). 
For Y. pseudotuberculosis IP32953 an insecticidal activity was demonstrated against 
Manduca sexta larvae (Pinheiro and Ellar, 2007). So far, not much is known about 
the expression pattern and regulation of genes involved in colonization of insects by 
Y. pseudotuberculosis. However, it is likely that the temperature-dependent bistable 
expression of RovA is not only advantageous during shifts between a free-living 
lifestyle and the mammalian host, but could additionally favour the colonization of 
insects.  
 
4.5 Tightly adjusted bistable rovA expression is crucial for 
virulence  
The major aim of this study was directed to investigate the physiological relevance of 
bistable rovA expression for virulence. Mouse infection experiments clearly 
demonstrated that precise RovA-levels seem to be very crucial for full virulence of 
Y. pseudotuberculosis in mice. Y. pseudotuberculosis YPIII mutants which express a 
stabilized version of RovA, resulting in formation of larger RovA-positive 
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subpopulations especially at 37°C, were strongly attenuated in the mouse infection 
model. These mutants were impaired in colonization of Peyer’s patches, caecum and 
MLNs. Especially the initial colonization of the Y. pseudotuberculosis YPIII ΔrovA 
mutant and mutants, which express the stabilized RovA variants, seems to be 
delayed in mice. At day five post-infection the differences in the bacterial load 
between the wild type and the mutants during the initial colonization were almost 
diminished. In the PhD thesis of R. Geyer it was demonstrated that a 
Y. pseudotuberculosis YPIII ΔinvA mutant is also delayed in colonizing mice, which 
indicates that the attenuated colonization in the Y. pseudotuberculosis YPIII ΔrovA 
mutant arise due to the lack of induction of invA expression by RovA.  
This study further revealed that higher amounts of invasin are produced at 37°C in 
the mutant strain expressing the stabilized RovAP98S, G116A, SG127/128IK variant. Invasin is 
important for the initial invasion of host cells, but is not expressed in the wild type at 
later infection stages (Nagel et al., 2001). Furthermore, invasin is highly 
immunogenic and leads to recognition by the host-immune system. It interacts with 
β1-integrins on host cells and induces the release of cytokines and activation of NF-
κB during uptake by the host cell (Grassl et al., 2003; Kampik et al., 2000; Schulte et 
al., 2000). Recently, it was also shown that invasin induces formation of neutrophil 
extracellular traps in Y. pseudotuberculosis strains lacking the T3SS (Gillenius and 
Urban, 2015). These findings support the hypothesis that expression of invA in an 
increased portion of cells at later infection stages due to the stabilization of RovA 
might lead to a stronger reaction of the immune system, which could promote a faster 
elimination from infected medium. In order to prove this hypothesis, the production of 
cytokines and innate/adaptive immune cell dynamics should be analysed in future 
experiments. 
Besides invA, it was described that RovA also affects central metabolic pathways in 
Y. pseudotuberculosis. Fluxome analysis of a Y. pseudotuberculosis YPIII ΔrovA 
mutant for instance revealed an increased pyruvate secretion during growth on 
glucose (Bücker et al., 2014). Moreover, the flux through the acetyl-CoA-tricarboxylic 
acid cycle was reduced in a Y. pseudotuberculosis YPIII ΔrovA mutant, which is 
caused by the lack of carbon in the core metabolism through the increased pyruvate 
secretion (Bücker et al., 2014). Moreover, a Y. pseudotuberculosis YPIII ΔrovA 
mutant was shown to be able to grow on nucleosides and the genes nupC1 and 
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nupC2 encoding for nucleoside transporter, are up-regulated (Bücker et al., 2014; 
Heroven, AK., unpublished data). It is feasible that some RovA-positive cells are 
important to prepare the population to survive in a future environment, e.g. by up-
regulation of nucleoside transporters, while an increased portion of this 
subpopulation of RovA-positive cells might be disadvantageous and therefore leads 
to an attenuation in virulence. Hence, a tight regulation of bistable rovA expression is 
crucial for virulence of Y. pseudotuberculosis. 
 
4.6 Model of bistable rovA expression during infection 
This study revealed for the first time expression of the virulence regulator RovA in a 
small subpopulation of Y. pseudotuberculosis in the Peyer’s patches and the caecum 
during infection. According to the current data, a hypothetical model of bistable rovA 
expression at different infection stages was developed (Fig. 4.2). 
Y. pseudotuberculosis, adapted to the external environment and entering the host via 
contaminated food or water, is flagellated and expresses RovA, which activates invA 
expression. Invasin promotes uptake into M-cells and transcytosis to Peyer’s 
patches. The temperature shift from environmental to host body temperature leads to 
changes in the expression pattern. After clonal invasion of the Peyer's patches a 
growing microcolony consists of two subpopulations with either high or low rovA 
expression. The majority of cells are in a RovA “OFF” state, in which consequently 
invA expression is turned off and the pathogen is less immunogenic. During 
persistence of Y. pseudotuberculosis in the caecum, the expression pattern changes 
again, whereby signals as nutrients, pH, ions and oxygen might be important. The 
signals are for instance sensed by the two-component systems BarA/UvrY and 
PhoP/PhoQ. Two different subpopulations can be found with either high (RovA “ON”) 
or low (RovA “OFF”) rovA expression. Cells in the RovA “ON” state are well prepared 
to re-infect the host or infect new host by shedding into faeces. 
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Fig. 4.2 Hypothetical model of bistable rovA expression at different infection stages.  
During primary infection bacteria adapted to the external environment are RovA-positive (RovA “ON”) 
and express early-stage virulence factors as invasin, which promotes interaction with β1-integrins on 
M-cells and transcytosis through the M-cells to underlying Peyer’s patches. Temperature is the main 
inducing signal to change the expression pattern. While in the Peyer’s patches most cells are RovA-
negative (RovA “OFF”) and express genes important for the later phase of infection as genes 
encoding for the T3SS, some cells still express rovA (RovA “ON”). At the persistent infection stage 
factors as nutrients, pH, limited oxygen and ions are signals to change the expression pattern again 
leading to two subpopulations, which are either RovA “ON” or RovA “OFF”. Expression of rovA 
contributes to re-infection and spreading to new hosts by shedding into faeces. 
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5 Outlook 
The present study demonstrated that rovA of the enteric pathogen 
Y. pseudotuberculosis is expressed in a bistable manner during infection. Although 
most bacteria do not express the virulence regulator RovA during infection, a small 
subpopulation of RovA-positive bacteria were found in Peyer’s patches and caecum 
at day three post-infection. In order to clarify whether rovA is bistable expressed in 
MLNs, liver and spleen or if it is restricted to gut-associated tissues, expression 
analyses should be also performed in these organs. However, it is likely that at early 
infection stages the bacterial load in the systemic organs might be too low to observe 
bistable rovA expression. To overcome this problem an alternative infection route, 
e.g. intravenous injection could be chosen. To elucidate the benefit of bistable rovA 
expression and the generation of two different subpopulations, it is important to gain 
more information about the amount of rovA-expressing cells at different infection 
stages, e.g. at one, three, five and seven days after infection. Since an impact of 
RovA during persistence is assumed, investigations concerning bistable rovA 
expression after a long infection period are required to prove the hypothesis. This 
could also reveal if rovA is more induced expressed during the persistent infection 
state.  
Additionally, it was shown that bistable rovA expression is advantageous for 
pathogenesis of Y. pseudotuberculosis during infection of mice. A 
Y. pseudotuberculosis YPIII ΔrovA mutant and mutants expressing stabilized RovA 
variants are significantly attenuated in virulence. To test if invasin overexpression in 
the stabilized RovA variants is the main cause of the attenuation, invA should be 
deleted in those mutants and compared to the respective invA+ strains. In this 
context, intravenous injections should be performed to avoid differences during 
primary host colonization due to InvA-mediated M-cell invasion. In order to address 
the question if the host immune response is altered as a consequence of stabilized 
RovA, immune response analyses and cytokine production assays should be 
performed. Moreover, a mutant, that constitutively expresses rovA at host body 
temperature (37°C) should be constructed and analysed in vivo in regard to survival 
and organ colonization of mice. This mutant could be compared to a strain, which 
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constitutively expresses invA in order to prove whether invasin is exclusively 
responsible for the phenotype or if other factors are involved. 
In order to gain information on the biological function of bistable rovA expression, 
genes, which are differentially expressed in RovA-positive and RovA-negative cells, 
should be analysed in more detail. For this approach, transcriptome or proteome 
analyses, combined with previous cell sorting, could be performed to dissect the 
genes/proteins, which are differentially expressed in the RovA-positive and RovA-
negative subpopulation. As the amount of RovA-positive cells might be too low in 
Y. pseudotuberculosis YPIII wild type, RNA-sequencing analyses of a ΔrovA mutant 
and a strain constitutively expressing rovA, could be compared to the wild type and 
might reveal differences in host and pathogen responses. 
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6 Summary 
The enteropathogen Yersinia pseudotuberculosis switches routinely between a free-
living lifestyle and host colonization. The bacterium is thereby confronted with 
different environmental challenges, such as nutrient fluctuations, responses of the 
host immune system, and the necessity of host cell invasion. The bistable expression 
of important regulators is an advantageous mechanism, evolved in order to survive 
rapid changes of environmental conditions. RovA of Y. pseudotuberculosis is a 
protein thermosensor regulating early-phase virulence genes, such as invasin. Due 
to conformational changes, the regulator recognizes temperature shifts, which occur 
when invading a host. RovA was shown to be expressed in a temperature-dependent 
bistable manner in Y. pseudotuberculosis leading to RovA “ON” and RovA “OFF” 
subpopulations within a certain temperature range. 
In the present study, the mechanisms leading to the establishment of bistable 
expression of rovA and its role during infection were investigated. Time-lapse 
microscopy was employed to examine the dynamics of the switching-process of 
bistable rovA expression, revealing hysteresis, a memory-like behaviour of cells. The 
analysis of different RovA mutants demonstrated that the thermosensing capacity 
and proteolysis of RovA are important for accurate bistable rovA expression. Besides 
temperature-dependent factors influencing bistable rovA expression, PhoP of the 
two-component system PhoP/PhoQ was found to affect bistable rovA expression. 
PhoP, which responds to low Mg2+-concentrations and antimicrobial peptides, was 
discovered to indirectly activate rovA expression through direct interaction with the 
non-coding RNA CsrC of the carbon-storage regulator system and connects two 
regulatory networks. Thus, the first direct activator of csrC transcription in 
Y. pseudotuberculosis was identified in this study.  
Furthermore, this work uncovered the existence of RovA-positive and RovA-negative 
subpopulations in murine Peyer’s patches and murine caecum during the infection of 
mice. Moreover, it was demonstrated that mutants expressing stabilized variants of 
RovA are clearly attenuated in virulence similar to a rovA deletion mutant.  
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In summary, this study reveals that bistable rovA expression is very robust to 
perturbations and that precise RovA-levels are crucial for Y. pseudotuberculosis to 
achieve full virulence. 
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Fig. S1 Gating strategy for bacteria of in vitro cultures.  
Exemplary gating strategy of bacteria, which were grown to exponential growth phase and fixed with 
4% paraformaldehyde. At first, bacteria were gated according to their size. Then duplets were 
excluded and eGFP-positive and eGFP-negative cells were gated dependent on the fluorescence 
intensity. 
 
 
 
Fig. S2 Amount of Invasin on the cell surface equals RovA-dependent eGFPLVA expression.  
Y. pseudotuberculosis YPIII cells harboring plasmid pKH70 (ProvA-egfpLVA) were grown to exponential 
growth phase at 32°C, fixed with 4% paraformaldehyde and stained with a specific monoclonal InvA 
antibody. As secondary antibody IgG-Cy5 was used. The cells were visualized using the Axiovert II 
fluorescence microscope (Zeiss) (performed by Nuss, A. M.). 
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Fig. S3 Plasmid loss three days after infection of mice.  
BALB/c mice (n=11) were orally infected with 2*108 CFU of either Y. pseudotuberculosis YPIII wild 
type or YPIII RovAP98S, G116A, SG127/128IK (YP287) harboring plasmids pFS48 (Ptet-mCherry) and pKH70 
(ProvA-egfpLVA). Three days post infection the number of bacteria in caecum and Peyer’s patches was 
determined by plating on LB-agar with and without antibiotics. Data were normalized to CFUs without 
antibiotics. 
 
 𝐝𝒓𝐝𝒕 = 𝜶𝟎+ 𝜶 𝒓𝒉𝒂𝒌𝒂(𝑻)𝒉𝒂 + 𝒓𝒉𝒂 𝒌𝒓(𝑻)𝒉𝒓𝒌𝒓(𝑻)𝒉𝒓 + 𝒓𝒉𝒓 −   𝜹 𝑻 ·   𝒓 
 
α0  basal production rate of RovA 
α  maximum induced production rate of RovA 
r concentration of RovA 
T  temperature 
ka  binding constant for activating binding site 
ha  Hill coefficient for activating binding site 
kr  binding constant for inhibitory binding site 
hr  Hill coefficient for inhibitory binding site 
δ  degradation and dilution rate of RovA 
 
Fig. S4 Differential equation for bistable rovA expression. 
The differential equation describes the parameters involved in the establishment of bistable rovA 
expression (Müller J.; Münch R., unpublished data). 
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